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ABSTRACT
The present study investigated the hypothesis that two 
subgroups of Parkinson's Disease patients nay exist: 
those susceptible to dementia and those resistant to 
dementia. The sample comprised 43 white patients (26 
males and i? females), all receiving levodcpa therapy. 
Cognitive functioning was assessed using subtests from 
the WAIS and abbreviated scales from Liria's Neuro­
psychological Investigation. Three cognitive components, 
namely general intellectual functioning, memory span 
and linguistic skills, emerged from a principal component 
analysis of the test scores. Unidimensional and multi­
dimensional cluster analytic investigations of the 
component scores failed to demonstrate the existence of 
patient subgroups. The cognitive functioning of the 
patient sample was characterised by a continuous distribu­
tion with the demented patients representing the severely 
impaired extreme. The influence of five patient variables 
on cognitive functioning in Parkinson's Disease was 
examined using stepwise multiple regression analyses. 
Present age, age at onset, duration of illness, depression 
and sex acted as predictor variables. The three time- 
related variables emerged as important determinants of 
dementia but, because of their high intercorrelation, their 
individual influences were difficult to establish. The 
influences of depression and sex proved to be negligible. 
The findings of thu prudent study were reviewed against 
the background of recent histopathological evidence of 
the involvement of both subcortical and cortical brain 
structunio in the Parkinson's Disease process.
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'Pavlov, when discijSBimt the question of a 
'respiratory centre', was compelled to 
recognise ♦■hat, 'whetcas at the beginning 
wo thought that this was something the size 
of a pinhead in the medulla...now it has 
proved to be extremely elusive, climbing 
up into the brain and down into the spinal 
cord, and at present nobody can draw its 
boundaries at all accurately'."
From Luria's "Working Brain" (1973, p . 30)
CHAPTER 1
INTRODUCTION
Over 170 years have pasL since J.imes Park!nson first 
described tho "shakin<! palsy" which was later to bear 
his name. Yet it is only over the last 15 years that 
significan ■strides h a w  boon mado towards undcrstanding 
the highly complex nature ol Mrkinson's Disease. The 
advent of levodopa In the ’.at-- 1960's provided tho spark 
for sustained and intensive roe.oarch. Designed to monitor 
the therapeutic value of flic dri>', lovodopa research 
inevitably uncovered new know:edg; of t-he disease process
Levodopa proved to be a "wonder drun" (Bv.ifdsley 6 Puletti,
1971) and today is widely accep.'d as the treatment of 
choice for Parkinson's Disease. As the immediate precursor 
of dopamine - the nourotransmittor deficient in Parkinson 
sufferers - lovodopa provides an excellent clinical model 
of pharmacological replacement therapy (Whitchouse, Hodreen, 
White 6 Price, 1983). By providing dopamine replenishment,
] evodopa has proved t:n effectively alleviate the motor 
disorder associated with Parkinson's Disease and appreciably 
improve the quality of life of sufferers. But levodopa has 
failed to provide a cur e .
Parkinson's Disease manifests primarily as a motor disorder 
with diagnosis established on ihe basis of characteristic 
motor symp tomotology . But. now attention has become 
focussed on cognitive impairment, a symptom that clinicians 
have long observed to be prevalent among Parkinson sufferers
vand which is sufficiently severe in some cases to manifest 
as dementia. Whether or not a dementing process forms 
part of the clinical picture of Parkinson's Disease has 
continued to be an issue of some controversy.
It has been established that those extrnpyramidal structures 
involved in the disease pathology - the nigrostriatal 
pathway - serve a motor function. Accepting -i dementing 
process as part of Parkinson's Disease moans either that 
these structures play a role in cognitive functioning 
or that the pathology is more diverse, extending beyona 
the extrapyramidal system. No longer could Parkinson’s 
Disease be definitively described as a dopamine deficiency 
syndrome with pathology limited to the basal ganglia.
The concept of "subcortical dementia", as opposed to 
"cortical dementi.)", has been proposed as an explanation 
of dementia in Parkinson's Disease ([(oilman a Valenatain, 
1979!. This supports the view of disrupted dopaminergic 
connections with subcortical structures as being the 
causative factors in the dementia. While this view has 
been adopted by various researchers ( Marttila & Rinne,
1976; Mortimer, Pirozzolo, Hansel) & Webster, 1982! , 
others have disputed that subcortical dementia exists as 
a clinical entity (Mayeux, Stern, Rosen & Benson, 1983; 
Whifcehouse et al., 1983) .
Establishing the locrliza*-ion of higher mental functions 
continues to be a relatively elusive task for brain 
research, but historically "higher mental functions" have 
been synonymous with "higher cortical functions". With 
hindsight, it is difficult to understand why more serious 
attention was not afforded to the findings of Alvord and 
his associates who, as early as 1965, found that a common 
feature of Parkinsonian b ra1-- at post-mortem was diffuse 
cortical atrophy (Polla- ibrook, 1966) . This
atrophy takes the for,. ibrillary tangles and
senile plaques, strongly suygestive of Alzheimer's Disease 
(Boiler, Mizutani, Roessm.m & Gambetti, 1980). It has 
been suggested tiiat Parkinson's Disease and Alzheimer's 
Disease coexist in demented Parkinson patients and this 
would provide the neurop-ithological basis for the 
Parkinson dementia. clinically, an overlap between 
dementia and parkinsonism is well-known. Drachman and 
Stahl (2 97!;) described dementia and parkinsonism as being 
two ends of a continuum rather than two distinct entities. 
However, .1 mmrop.it he! i«i ivul I'sp] nnu l.ion for the overlap 
was iitill in in' found.
l>erh.ips the most excilinq research findinq in this regard 
is the recent implication of another neurotransmitter, 
acetylcholine, in the Parkinson's Disease process. The 
diminished cortical activity of acetylcholine, seemingly 
as a result of a dmjcncratlve process which begins at a 
subcortical level, effectively provides a link between 
the cognitive and motor disorders of Parkinson's Disease 
IWhitehouse et. al., 1983). One disease process could be 
responsible for both the motor and cognitive aspects of 
the disease rather than two disease processes, namely 
Parkinson's Disease and Alzheimer's Disease, coexisting 
in certain patients.
But not all Parkins.., sufferers become demented and not 
all Parkinsonian \>ro - -ihow evidence of cortical atrophy. 
Parkinson's Diseaso li; k.iown lo bo extremely variable.
Lavy, Melamed, Cooper, Kent in & Rinot (1979) described 
Parkinson's Disease n„ , complex of several processes 
rather than a single tiinoase entity. Riklan (2972, p. 44) 
stated that Pavisinson'a Discvie is "not a unitary or 
homogeneous disease but involve« •‘t extremely wide variety 
o£ both neurological and behavioural signs in different 
patientis". Could Knhqroupr; of sufferotr possibly exist?
The idea of patient subgrouns ie not now. Observations 
within the treatment sit ition often leaves the clinician
1
with the impression o: a relatively non-deteriorating sub­
group of sufferers. Pollocks liornabrook (1966) refer to 
"stationary" forms of the disease evident in patients whose 
illness does not progress with the same severity as other 
sufferers. Rinne (1978) talks of "benign" and "malignant" 
forms of the same disease process.
Research has provided empirical support for these theoret­
ical views. Garron, Klawans am! Narin (1972) identified 
two grc .:ixs of sufferers who differed in ini-.eJ lectual 
f.inctioniny attributable to cUfferenl ages of symptom onset. 
T-.ese results were echoed in the findings of Liebcrman, 
Dziatolowski, K v.perstui th , Serby, Goodgold, Korein and 
Goldstein (I'1/?). Sweet, McDowell, I’ciytnson, Loranger 
and Goode 11 (197CO -lathered ros'ults which supported the 
possible existence of two P.trkinson's Disease processes:
Levy bodies disease confined to r.ubeortieal areas and 
Alzheimer neurofibrillary tamiles disease involving 
cortical areas as well. Boiler et. al. (1980) also suggest, 
on the basis of clinicaJ and patholoijj cal eviderco, the 
existence of two different, disease processes: Parkinson’s 
Disease with dementia and Park:nuon'<; Disease without 
dementia. Mortimer, Pi HunHCii and Webster (1982)
divided sufferers into two groups based on the presence 
or absence of dementia in relation tn certain motor 
symptomoto2o</y.
In contrast l.o these findings, I-1 ro-.zolo, Hansch, Mortimer, 
Webster and Kuskowskj (1982; (m ried out a particularly 
extensive neuropsychological e - ,-iy. They found that, with 
regard to intellectual f u n d  !<■ t• c;, Parkinson sufferers 
form a homogeneous qroup. To" icori'u slmwed no evidence 
of bimodality bui rather show - '.v ients1 functioning to 
fall along a continuum, front ■ .ntact to the severely 
impaired.
The present study naa been und. -laken in an effort to 
clarify the discrepant data available on the cognitive
impairment in Parkinson's Disease sufferers. Encouraged 
by the clinical experience of the staff of the Parkinson's 
Disease Clinic at the Johannesburg General Hospital, 
our objective was to investigate *'ic possible heterogeneous 
nature of the Parkinson group of sufferers.
It was hypothesised that two subgroups of sufferers exist: 
those susceptible to dementia and those i isistant to 
dementia. Our task war, to distinguish one group from the 
other on the basis of demographic 'ata. Being able to 
"predict" dementia by identifying a vulnerable group, 
would not only increase our understanding of the Parkinson 
dementia but would also assist in the forward planning 
of patient management. Most importantly, it could presage 
uiternarivo or additional treatment regimens.
CHAPTER 2
THE NEUROPATHOLOGY OF PARKINSON'H PlSKftSE
Parkinson's Pi sea so (PD) is a progress, i vu doyonoratlve 
disease of the central nervous system. Onset of the 
disease generally occurs in into middle eg« <50-60 years) 
but may or lur later. The disease is of unkiiown etiology 
bu several theories have Ik on pos t ulnt.ob. Slow virus 
infections (Rinne, 1'i 78) , he a w  metal intoxications 
(Heilman i V.ilvns' e i n , I an autoimmune response 
(Abramsky K Litvin, 19 78) , .in aggravated aging process 
(Mann & Vat o s , and a genet i r component (Martin,
Vouna s Anderson, i:'73) !iavo all been proposed as being 
pathoacnic factor;..
Clinically, patients present with certain motor symptom- 
otology which provides the basis for diagnosis. These 
symptoms are tremor, rigidity, bradykinesia and a gait 
disorder (Draper, 198(1; LLeberman, 1974 ) . Cognitive 
impairment, and depressed affect arc associated symptoms 
but are scklomly diagnos tieal ly relevant.
No .ropatholoyleally, the disease is characterised by 
lotions of the basal ganglia. The degenerative process 
results in a loss of pigmented neurons in the pars compacta 
of the substant.ia nigra with similar changes occurring 
in the locus eeruleuis and the dorsal motor nucleus of 
the vagus. To a lesser extent, there is n depletion of 
small nerve cells in the globus pa11idus (Pearce, 1978). 
Lcwy bodies arc characteristically found spread throughout 
these areas but arc particularly evident in the substantia 
nigra and locus cerulcus (Hakim & Mathioson, 1979) .
Generalised cerebral atrophy has been found to occur i.n 
a disproportionate number of PD sufferers (Pearce, 1978).
The atrophy rkes the form of senile plaques, neurofib­
rillary tany.es, yranulovacuolar degeneration in the 
hippocampus and neocortical cell loss (Hakim s Mathieson, 
1979). These histologic features are indistinguishable 
from Alzheimer's Disease (AD), the dominant disorder 
producing dementia in the elderly (Terry S Katzman, 1983) .
Biochemically, PD is characterised by a deficiency of the 
neurotransmitter, dopamine, and its metabolic end-product, 
homovanillic acid (Markham, Treciokas & Diamond, 1974).
Tho nigrostriatal fibre system is uhe largest single 
dopar.ino-containing pathway in the human brain. The cell 
bodies are imbedded in die pars compacts of the substantia 
nigra with axons projecting at the caudate nucleus and 
putamen (Abrams: - & Litvin, 1978). The well-documented 
clinical success of levodopa, the dopamine precursor 
substance, suggests pathology only at a presynaptic level 
but pharmacological investigations indicate post-synaptic 
impairment as well (Abramsky R Litvin, 1978; Rinne, 1978).
It remains possible that the loss of dopamine could result 
from a primary defect in Its metabolism rather than 
necessarily result from the degeneration of dopamine pr o ­
ducing cells (Yahr, 1^77). While a dopamine deficiency 
has now been undeniably established as the major biochemical 
correlate of the motor symptomotology of PD, so much of 
dopamine's complex activity still remains hypothetical.
Other neurotransmitters have been investigated in relation 
to the PD process. Gamm -aminobutyric acid, noradrenaline, 
serotonin, peptidcrgic neurons and monoamine oxidases are 
all reduced in farkinron patients. Their role, if any, in 
the pathology of the disease remains uncertain but their 
activity is more likely to be secondary than primary to 
the disease process (Pearce, 1978; Rinne, 1978).
One neurotransmit ter which new evidence is increasingly 
implicating is acutylcholine. The striatum contains an 
abundance of cholinergic neurons. The ao*-.vity of 
acetylcholincstcrase (in the presence of which acetyl­
choline is broken down) in the substantia nigra suggests 
the possibility of cholinergic striatal or pallidal 
projections in the substantia nigra (Iversen & Iversen, 
1975). While the striatal dopaminergic system serves an 
inhibitory function, the striata. cholinergic system 
serves an excitatory function (Abramsky & Litvin, 1978). 
Research studied suggest that dopamine and acetylcholine 
operate in a delicately balanced system to control certain 
aspects of behaviour (Iversen & Iversen, 197' and this 
balance is achieved by the activity of  these two neuro­
transmitters existing, in a specific ratic* with one another. 
Once the balance of activity is disturbed, dysfunction of 
the basal ganglia results in the Parkinson condition 
(Abramsky s Litvin, )97S). Dopaminergic activity is 
reduced and cholinergic dominance occurs. Pearce (1978) 
postulates that when dopaminergic neurons fail and abandon 
the receptors in the s triatum,cholinergic neurons sprout 
to t.ikc their place resulting in a further increase in 
the striatal cholinergic system. This would explain why 
anticholinergic agents have had some therapeutic success
Besides the cortical atrophy mentioned earlier, other 
neuropatho logical and biochemical features are shared by 
PD and f.n. All PD patients show a dopamine deficiency 
in the basal ganglia but some patients with PD also chow 
cholinergic deficiencies in the cortex reminiscent of AD 
(Whitehouse et al., 1983). The loss of cholinergic neurons 
in the basal forebrain, and in particular the nucleus 
basalis of Meynert, has bean demonstrated In AD. "The 
loss of neurons in the nucleus basalis of Meynert is the 
principal pathological substrate of the consistently 
demonstrated loss of presynaptic cholinergic markers in
the cortex of Alzheimer sufferers•' (Whitehouse et a l . ,
1983, p. 245). Now, loss of cholinergic neurons in the 
nucleus basalis of Meynert has also been established in
The nucleus basalis of Meynert has been implicated in PD 
for many y e ars. Whitehouse et al. (1983) refer to Lewy's 
1913 findings and write: "The original observations of 
Lewy bodies, the classic intracyLoplasmic inclusions 
almost pathognomonic of idiopathic PD, were made not in 
the substantia nigra but in the substantia innominata, 
an area encompassing the nucleus basalis of Meynert”
(p.245). Yahr, Wolf, Antuncs, Miyoshi and Duffy (1972) 
also reported Lewy bodies in the innominate (basal) nucleus.
The involvement of the nucleus basalis of Meynert not 
only effectively provides a morphological basis for the 
dementia in PD but also provides a neurological link 
between the subcortical and cortical degeneration in PD.
The first evidence of Alzheimer-like changes in demented 
patients with PD suggested that these patients may have 
PD with concomitant AD (Hakim s Mathieson, 1979) but it 
now appears that the same degenerative process may be 
responsible for nigrostriatal lesions and the cortical 
atrophy in PD (Mental changes, 1974). It also significantly 
asserts the diffuse neurological influence of the PD 
process.
A dementing process must be acknowledged as part of the 
clinical picture of the PD process but this does not 
detract from the possibility of n subgroup of sufferers 
who may be resistant to this dementing process. Also, 
while the above neurological premise may explain both 
the cognitive and motor symptoms of the disease it 
does not account for the associated affective symptom- 
otology, namely depression.
Incidence figures for depression in PD vary from 37%
(Celesia & Wanamaker, 1972) to 90S (Mindham, 1970).
However, the latter study investigated depression in e 
hospitalised patient group suffering from "a mental illness" 
and can hardly be regarded as representative of the PD 
population. But Markham et al. (1974) also propose a 
high figure of 76% before treatment. Despite the discrep­
ancies, the incidence of depression has been sufficiently 
high to arouse research interest.
The major issue with regard to the prevalence of depression 
in PD sufferers is whether the symptom is an understandable 
emotional reaction to a severely disabling disease or 
directly associated with the disease process. Two studies 
compared depression scores of a Parkinson group with 
sufferers of other equally disabling conditions. The 
first (Horn, 1974) included a paraplegic group while the 
second (Robins, 19 76) included a 'rely physically
disabled group, mostly hemipleg to cerebrovascular
disorder. These control groups cute patients who,
like Parkinson sufferers, have enormous limitations 
placed on their mode of )ife by irreversible physical 
conditions and yet both studies clearly indicated that the 
Parkinson groups were significantly more depressed.
The Parkinson depression frequently seems to be out of 
proportion to the neurologic deficit (Mental changes, 1974) . 
Also, reports of depression failing to lift despite 
improved motor functioning following treatment lend further 
support to depression in PD being other than reactive 
(Marsh 8 Markham, 1973). Depression suffered by PD 
patients appears unrelated to factors such as length of 
illness, severity of disability, age or sex (Celesia & 
Wanamaker, 1972; Hor n , 1974; Markham ct al., 1974;
Robins, 1976) and is seemingly independent of the dementing 
process (Lieberman et a l , 1979; Markham et al., 1974;
Mayeux, Stern, Rosen s Lcventhal, 1981). This suggests
that the neurological substrates of the affective disorder 
may be different to those underlying other aspects of the 
disease.
Mayeux et a l . (1981) found a significant relationship 
(but not necessarily causal) between cognitive impairment 
(but not dementia) with depression. Again, the possibility 
of subgroups is proposed. They suggest two types of 
intellectual impairment accompanying PD: one group 
(approximately 30% of the patient population) consists 
of globally demented patients suffering from coexisting 
PD and AD while a second group (approximately 50%) 
is made up of patients with a mood disorder and some 
degree of cognitive impairment but no global dementia.
This presumably leaves a third group (20%) who remain 
intellectually intact.
The pathophysiology of depression in PD remains uncertain. 
Biochemically, the genesis is unlikely to be attributable 
to a dopamine deficiency. Depressed patients, other than 
PD patients, are not generally dopamine deficient (Bunney, 
1970) and there remains no clear correlation between 
dopamine metabolism and depression (Mayeux, 1982). Attention 
has been given to brain monoamines. Norepinephrine and 
serotonin are reduced in both patients with depressive 
disorders and PD patients (Celesia & Wanamaker, 1972;
Mayeux et al., 1981; Robins, 1976) but these reduced levels 
have not boon shown to be causal factors.
Mayeux et al. (1981) propose the involvement of the 
hypothalamus in the depressive condition. Ihe hypothalamus 
appears to be another site of disease pathology. Neuronal 
loss and Lewy body formation have been : iown to occur, 
particularly in the nondopaminergic pal ;ways of the tuber- 
mamillary, posterior and lateral nuclei (Yalir, 1977). This 
evidence, in conjunction with PD endocrine studies, suggests 
hypothalamic abnormality. "Whether degenerative changes
in the brainstem and hypothalamus with resultant loss 
of central monoamines produces or predisposes the 
individual to depression in PD remains to be determined" 
(Mayeux et al., 1981, p. 649). When one considers that 
integration of higher mental functions such as memory 
and cognition (Mayeux ct al., 2 9 8 1) as wclj as emotional 
expression and arousal fJordaan, Jordaan & Nieuwoudt,
1975) have been attributed to the hypothalamus, the 
dysfunction of this brain structure in PD must be a 
possibility.
Additional signs of general brain changes in PD are the 
involvement of the mes^limbic and mesocortical dopamine 
systems in the disease pathology (Cicerone, 1982; Rinne,
1978) . The disruption of those systems may be a contribut­
ing factor in the emotional and intellectual disturbances 
(Mayeux, 1982) but the lack of conclusive evidence of 
dopamine involvement in depression provides an argument 
against this disruption playing a causative role.
Reports of levodopa's effect on depression have been 
inconsistent. The drug has been known to induce (Mindi-.am, 
1970), alleviate (Yahr, Duvoisin, Schear, Barrett 8 Hoehn, 
1969) and have no effect (Beardsley S Puletti, 19 7 1;
Marsh 5 Markham, 197 3) on depression. It would appear 
that in the short-term, Icvodopa treatment improves 
depression. Cclesia and Wanamaker (1972) showed a drop 
in the incidence of depression from 37? prior to treatment 
to 24% after treatment. Significant results were also 
obtained by Markham et a l . (1974), documenting a fall from 
76% to 4 3%. As both studies examined effects over the 
same period of time (18 months), differences are probaoly 
due to the use of different assessment techniques. T'ie 
trend, however, is similar.
Longer-term studies show an increase it. de;.xersion. Mayeux 
et al. (1981) found 47% of patients to depressed. Forty- 
three percent of these patients (approximately 20% of the
the total group) were depressed prior to ievodopa treatment. 
More moderate increases, from 22% prior to Ievodopa to 
25% after 6 years of trcaLmonl, have? been noted (Levodopa: 
long-term, 1981). In a particularly long-term study,
Portin and Rinne (1980) tnund that depression rose sig­
nificantly after 8 to 10 yours of treatment following 
little change after 2 to i years of treatment. The reason 
for the increase renv ins unclear. Riklan, llalgin, Maskin 
and Weissman (1973) claim that the depression is mainly 
psychogenic in nature as a result of Ievodopa failing to 
cure the disease along with ongoing symptom deterioration. 
However, it should be remembered that PD patients 
are significantly more depressed than other equally dis­
abled patients. Levodopa has been shown to displace 
serotonin from serotonergic neurons and this could provide 
one biochemical explanation for depression following 
chronic treatment (Sweet ct a l ., 1976) but leaves unexplained 
the number of I’D p.nients depressed even before Ievodopa 
treatment.
Levodopa provides enormous benefit by significantly 
alleviating the clinical symptoms of PD sufferers and in 
so doing appreciably improving their quality of life 
(Cotzias, Papavasiliou & Gellene, 1969; Rinne, 1978 ;
Yahr ot al., )9r>?) . "Levodopa. . .nov only improves the 
symptoms, but prolongs the period during which patients 
are physically and socially independent” (Pearce, 1978, 
p. 1666). However, despite Ievodopa’s efficacy, it has 
failed to provide: a cur e . The natural course of the 
disease remains unaltered with the neurological degenera­
tive process continuing unnbatcnl (Rotez s Barbeau, 1973; 
Halgin, Riklan » Misiak, 1977; Markham et al., 1974;
Yahr, 1 9 77) . At autopsy, nigral, neurons in various stages 
of degeneration -suggest that the pathological disease 
process continues during Ievodopa treatment (Yahr et al.,
1972). While PD shortens life expectancy, chronic levo- 
tiopa treatment lengthens the life span of sufferers by, 
on average, some }4 years (Levodopa: long-term, 1981).
But while Levodopa stabilises the Parkins on clinical state, 
these desired results are temporally limited. According to 
Rinne (1978) , who presents a particularly thorough review 
of Parkinson research, levodopa's long-term therapeutic 
benefits may be summarised as follows:
- during the first 6 months a significant improvement 
of the Parkinson condition is achieved
- after 2 to 3 years a progressive decrease in overall 
performance capacity becomes evident
after 6 years the mean overall disability remains 
better than before treatment
- after 7 years levodopa’s therapeutic assistance is 
no lonuor evident.
Response to treatment varies from patient to patient but 
generally the above "timetable" applies. Because there 
appears to be a fixed period during which Levodopa is 
effective, Rinn-. !!"' ' nus suggested that Levodopa 
administration be withhold w H l o  symptoms are mild and 
only begun when the patient's condition necessarily 
warrants its use.
Ihe reason for levodopa's waning influence is still to be 
satisfactorily explained. Poderzoli, Girotti, Scigliano, 
Aiello, Carolla and Caraceni (1983) simply propose that 
response to dopaminerglcs may decline with a g e . Pearce 
and Pearce (1975) suggest that diminishing response to 
Icvodopa may bo due to dopamine receptor exhaustion.
The nigrostriatal pathway may be rendered inaccessible to 
exogenous dopamine possibly because so many nerve cells 
will have been lost that the oxtrnpyramidal system no 
longer has the capacity to maintain functional status 
(Rinne, 1978) . Fading benefits may be due to a combination 
of factors such as aging in conjunction with progressive 
disease deterioration.
Levodop i-eatment has not been without troublesome 
side-effut ; To optimisc therapeutic effocts, levodopa 
has been c ■ ^ mo^i v/i • n j dcc.ir)x?xylase inhibitor and is 
of'-on adminisi. Ti'tl alonq with anticholinergic agents and 
antidnpressant=. uiwovor, i.mntal disturbances following 
levodopa admifusi r.at ion have often been reported (Celesia 
6 Barr, 1970; Jenkins & Groh, 1970), rangincj from confusion 
and disorientation to psychosis, anxiety and euphoria.
The more extreme side-effects are invariably experienced 
by older patient?- with associated organic brain syndrome 
(Celesia s Barr, 1970). Luvodopa has been found to 
aggravate already exisiinq dementia (O'Brien, Digiacomo,
Fahn & Schw.n---, ! 9 ;  Sacks, Kohl, Messeloff & Schwartz,
1972 and it would : ■ -cm I ha I ihr patient's age and pre- 
exis’ ing dementia w u l U  prodist. '-o patients to levodopa- 
induced psychiatric disturbances. Pederzoli et a l . (1983) 
found that age of symptom onscc is a relevant consideration 
in predicting side-effects. Patients with disease onset 
oef^re age 60 ar<’ more likely to experience abnormal 
— ■'vements and or.-off phenomena while patients with onset 
rov r-ige 60 arc more likely to experience major mental 
i;.-J.urbances. It would then seem that the ideal candidate 
r:jr levodopa therapy is the younger patient with good 
nremorbici emotional and intellectual status (Leiber, 19 77) .
The biochcmicTl ba$;in frr unfavourable responses to 
levodopa rnm.iins unclear. It would appear that an excess 
of dopamine as a result of. levodopa administration may 
displace other ami hffi from their normal storage sites and 
interfere with their metabolism {Celesia & Barr, 1970;
Yahr et al., 1969) . "Regions of the brain, such as the 
thalamus and cerebral cortex, which normally contain little 
or no dopawinc show significant concentrations of this 
monoamine and its acid motnbol.itn . . .after levodopa therapy" 
(Yahr et al., 1972 , p .64). Those findings may be of prime 
importance in understanding the mode and sites of action 
of levodopa in producing unwanted effects (Yahr et al., 1972) .
The value of levodopa as a therapeutic agent in the 
1reatment of PD is succinctly stated by Celesia and Barr 
(1970): "Side-offccts from levodopa are frequent, but
its benefits far outweigh its shortcomings" (p.197).
Riklan ( 1972) wrote: "The fact that the sa?r-e drug in 
similar doses, can lead to lethargy in some instances 
and sleeplessness in others, lo increased alertness in 
some and confusion in others, reflects some of the com­
plexity o f .. .biochemical-behavioural events" (p.44).
Those biochemical-behavioural events involve the inter­
action of individual patient variables, the activity 
of a highly complex drug and a highly complex disease 
process.
Although PP seems to have a particular affinity for the 
dopaminergic neurons of the substantia nigra (Rinne, 1978), 
neuropathology indicates that it does not observe the 
boundaries of the extrapyramidal system. The degenerative 
process is pervasive, interfering with the functioning of 
several brain structures and biochemical systems. The 
limits of disease influence arc yet to be established.
The important implication of the nucleus basalis of Meynert 
uncovered a neurological pathway along which degeneration 
transgresses from the subcortical areas to the cortex.
Other pathways may exist. It remains the task of medical 
and allied research to find them.
PARKINSON’S DISEASE AS A DEMENTING COMD3UION
Dementia may be loosely defined as ten acquired loss of 
intellectual functioning. It is a clinical symptom and 
is not in itself a diagnostic entity (Heilman & Valenstein,
1979) .
Clinically, the demented patient presents with impaired 
judgement, a lack of inright and will demonstrate abstract 
reasoning difficulties. His memory will be markedly 
affected, particularly short-term memory, to the extent 
that learning new skills will be almost imnossible.
Agnosia, aphasia and apraxia may occur. The patient is 
likely to be confused for time, place and person. He may 
present as highly distractable. He will probably be 
careless of his personal condition. He will manifest 
personality disturbances such as becoming increasingly 
eccentric, developing a rigid outlook and displaying 
diminished initiative. His interests will become restricted, 
there may be abrupt mood swings but affect will become 
progressively blunted or he may become depressed. His 
functional status will be markedly affected, restricting 
his independence and the normal activities of daily living.
Of the Parkinson patient population, approximately 305 
develop dementia (Levodopa: long-term, 1981; Marttila &
Rinne, 1.976; Maycux at a l ., 1981 ; Mindhnm, 1970: Sweet 
at al., 19 76), but because of the progressive nature of 
the disease, the figure may rise to as high as 505 before 
death (Bollor ct a 1.., 1980; Whitehouse et a l . , 1983) .
Levodopa .-is no ameliorative effect on the dementia 
(WMtehousc et a l., 1983) and the dementia will progress 
despite levodopa admdnistration. Markham et al. (1974) 
showed the incidence of dementia to increase from 26% 
prior to levodopa to 385 after 5 years of treatment.
However, dementia cannot he regarded as an effect of 
levodopa administration. Withdrawal of levodopa has been 
shown to decrease side-effects, such as confusion and 
agitation, ana lead to the worsening of motor symptor.is but 
leave dementia unchanged (Swret et al., 1976). Also, 
because histopaehological evidence indicates no difference 
between treated and non-treated patients (Yahr et al., 1972), 
no structural changes appear to occur as a result of 
levodopa administration. The organic syndrome producing 
the Parkinson dementi.-’ is most unlikely to be levcdopa- 
related.
The dementia associated with PD appears to be an age- 
related phenomenon. The demented Parkinson patient is 
older (Celesia 8 Nanamaker, 1972; Licberman et al., 1979), 
with onset of the disease occurring later in life (Garron 
et a l ., 1972 ; Marttila & Riune, 1976). Lieberman et a l . 
(1979) found few demented patients to have experienced 
symptom onset before age 60. Information regarding the 
duration of illness of the demented patient has been 
variable. Demented patientF have had the disease for a 
longer period of time (Celesia & Wanamaker, 1972) , a 
shorter period of time (Lieberman et al., 1979) and also 
show no significant diCferenc-u in disease duration 
(Marttila & Rinne, 1976) when compared with non-demented 
patients. However, in studies which show the demented 
patient not to have Le^n ill for longer (Garron et a l .,
1972), he has been more physically disabled (Lieberman, 1974) 
which suggests that his symptoms, and therefore the disease 
process, had progressrd more rapidly (Pederzoli et a l .,
1983). The dementia will progressively worsen and prove
irreversible. In fact, the dementia may well be more 
disabling than the motor disorder (Pollack & Hornabrook,
The Parkinson dementia cannot be accounted for on the 
basis of aging alone. Patients with PD are at a greater 
risk of dementia than the general population (Hakim & 
Ma.-hieson, 1978). Boiler et al. ( 1980) found the pre­
valence of neuropathological changes characteristic of 
AD (themost prevalent dementing disorder) to be more 
than six times that of age-matched controls. Lieberman 
et a l . (1979) found the incidence of dementia in PD to 
be as high as ten times that of age-matched controls.
It is therefore possible that the aging process in con­
junction with the degenerative disease process produces 
the dementia.
It appears that age of symptom onset is a major predispos­
ing factor in the development of the Parkinson dementia 
and therefoie could also be considered a determining factor 
in the course the disease will take. This would essentially 
be in accord with Doshay's view, cited by Pollack and 
Hornabrook (1966), that patients with disease onset early 
in life showed a slower progression of the disease.
Some may argue that two disease subtypes exist, namely 
early-onset PD (without dementia) and late-onset PD 
(with dementia). Garron et al. (1972) and Lieberman et al. 
(1979) would concede to this view. However, the s .me 
disease process may be altered by patient variables such 
as age at onset (although, of course, other variables 
may be influential). If we accept that there is one 
disease process, then the younger brain, for reasons 
unknown at present, may respond differently to the neuro­
logical disorder. It is possible that the younger, 
healthier brain produces some form of resistance to the 
disease, not to the extent that the disease process is 
halted, but at least "slowing" its spread.
Because the Parkinson dementia has so many correlates 
with AD, it is noteworthy that age at onset seems to 
result in different manifestations of AD with respect 
to biochemical activity in different parts of the brain 
(Bird, Stranahan, Sumi & Raskind, 1983). However, an 
age-related anomaly exists in that early-onset AD 
culminates in a more severe disorder while in PD early 
onset seems to predict a less severe disorder.
PD is not unique in manifesting as a motor disorder 
accompanied by a dementing process. Huntington's Disease 
(HD) and late AD are two cases in point and provide suit­
able comparisons to illustrate similar pathological 
spreads of degeneration that fail to observe neat neuro­
logical boundaries.
The primary site of lesions in HD and PD is the basal 
ganglia, a subcortical structure. The degenerative process 
begins in the substantia nigra in PD. In HD, it begins 
in the caudate nucleus and putamen. The basal ganglia are 
subcortical nuclei with extensive cortical and subcortical 
connections (Heilman s Valenstein, 1979) ,nd the influence 
of these primary lesions may be far more extensive than 
we have so far determined. Besides the subcortical 
involvement, both HD and PD have consistently been noted 
to include frontal lobe involvement (Barbeau, 1972;
Botez 6 Barbeau, 1973; Heilman & Valenstein, 1979;
Portin & Rinne, 1980). The motor deficits, lack of 
spontaneity and motivation attributed to frontal lobe 
lesions are evident in PD, HD and AD. These behaviours 
must involve a cognitive aspect, but. the cognitive func­
tioning associated with the frontal lobes may not only 
be related to motor and emotional regulatory behaviour. 
"Although superficially, the frontal lobes do not seem to 
be involved in maintaining intellectual abilities, we 
cannot accept this without further proof. There are in­
dications that the frontal lobes play a part in complicated
intellectual processes, e.g. in the application of abstract 
logic" (Jordaan et a l ., 1975, p. 144).
Although the genesis of degeneration in HD and PD occurs 
in a subcortical structure, both diseases seemingly involve 
cortical structures as well. The literature has noted 
generalised cortical atrophy occurring in PD but even if 
cortical involvement is limited to the frontal lobes this 
may be sufficient, along with subcortical involvement, to 
produce the related dementia.
In late AD a similar cj,.‘\tion prevails. Cognitive and 
motor symptoms conjoin, with extrapyramidal (or parkinsonian) 
features being demonstrated in demented patients. Drachman 
and Stahl (19 75) commented on the close relationship 
between dementia and extrapyramidal features, and observe 
that "often the decision as to whether a patient has 
dementia (with extrapyramidal signs) or parkinsonism 
(with dementia) is largely a matter of different emphasis" 
(p.809). Pearce and Pearce (1975) dispute that the rela­
tionship is that close as clinically one is, invariably 
able to distinguish the two disorders on the basis of 
the presenting symptom but they concede that as AD and PD 
become more severe and progressive the two conditions 
appear very similar.
If we accept Heilman and Valenstein1s 1979 classification 
of dementias on the basis of localisation, AD is an 
example of a cortical dementia while PD and HD are both 
examples of subcortical dementias. These divisions 
suggest that two forms of dementia exist,essentially 
different in locus of pathology as well as clinical 
manifestation. With regard to subcortical dementias,
Heilman and Valenstein (1979) state: "The hallmark of 
these dementias is the prominent appearance of signs 
relating to deficits in frontal lobe function without 
signs of language involvement" (p.485). Mayeux et a l .
(1983) cite previous descriptions of subcortical dementias 
and also note "no impairment of language" (p.278). r'rom 
this it could be deduced that cortical and subcortical 
dementias would produce differing patterns of intellectual 
impairment. Mayeux and his co-workers (1983) set out 
tc establish if subcortical dementia, as opposed to 
cortical dementia, is a recognizable clinical entity. They 
compared the intellectual functioning of patients with 
AD, HD and PD but discovered no differences in neuropsycho­
logical functioning to exist between the three groups.
This lead the researchers to believe that the divisional 
nomenclature Is misleading. Rather, a combination of 
cortical and subcortical degeneration may be responsible 
for the intellectual impairment in all three diseases.
It would be foolish to conclude that the dementia in these 
three diseases arises from the same morphological and 
biochemical changes. As Mayeux and his colleagues point 
out, AD and PD have some neuropathological similarities 
but AD and HD do not. Also, while we know that in AD 
and PD the dementing process occurs as a result of 
neuronal loss in the nucleus basalis of Meynert, and it 
is along this route that cortical cholinergic markers are 
eradicated, in HD the nucleus basalis of Meynert is left 
intact with levels of cortical cholinergic markers 
remaining relatively normal (Farhad, Clark, Folstein, 
Whitehouse, Hedroen, Price & Chase, 1982). AD and HD 
are used here as analogous examples to illustrate the 
pervasive effect, perhaps common to neurological degener­
ative diseases, which ultimately culminates in intellectual 
as well as motor disorders. It therefore seems that 
neurological diseases of this sort inevitably involve 
a spreading process, from cortical to subcortical areas 
as in AD, or from subcortical to cortical areas as in PD 
and HD. Any claim that the process is limited to any 
specific level would appear to be false.
(1983) cite previous descriptions of subcortical dementias 
and also note "no impairment of language" (p.2 78). From 
this it could be deduced that cortical and subcortical 
dementias would produce differing patterns of intellectual 
impairment. Mayeux and his co-workers (1983) set out 
to establish if subcortical dementia, as opposed to 
cortical dementia, is a recognizable clinical entity. They 
compared the intellectual functioning of patients with 
AD, HD and PD but discovered no differences in neuropsycho­
logical functioning to exist between the three groups.
This lead the researchers to believe that the divisional 
nomenclature is misleading. Bather, a combination of 
cortical and subcortical degeneration may be responsible 
for the intellectual impairment in all three diseases.
It would be foolish to conclude that the dementia in these 
three diseases arises from the same morphological and 
biochemical changes . As Mayeux and his colleagues point 
out, AD and PD have some neuropathological similarities 
but AD and HD do n o t . Also, while we know that in AD 
and PD t .e dementing process occurs as a result, of 
neuronal loss in the nucleus b-sali.s of Meynert, and it 
is along this route that cortical cholinergic markers are 
eradicated, in HD the nucleus basalis of Meynert is left 
intact with levels of cortical cholinergic markers 
remaining relatively normal (Parhad, C l ark, Folstein, 
Whitehousc, Hedreen, Price & C h ase, 1982). AD and HD 
are used here as analogous examples to illustrate the 
pervasive effect, perhaps common to neurological degener­
ative diseases, which ultimately culminates in intellectual 
as well as motor disorders. It therefore seems that 
neurological diseases of this sort inevitably involve 
a spreading process, from cortical to subcortical areas 
as in AD,or from subcortical to cortical areas as in PD 
and HD. Any claim that the process is limited to any 
specific level would appear to be false.
PD has a varied and extensive influence on the behaviour 
of sufferers. Perhaps an earlier return to a holistic 
view would have provided a more satisfactory framework 
in which to conceptualise brain dysfunction in PD. 
Divisions based on localization have produced a somewhat 
blinkered view with investment in PD being simply regarded 
as a motor disorder. There can no longer be informed 
resistance to PD being a dementing condition.
CHAPTER _4
COGNITIVE I MPA IJiMENT IN PARKINSON'S DISEASE
From wli.it has been said, the impression may have been 
created that PD r.ut'fevers either remain intellectually 
intact or become denient.oit. In reality a range of 
impairment exists between these two extremes. Early 
thinking was that these eo<mi t i ve changes were accessory 
or fortuitous occurrences and not part of the disease 
process (Pollack & Hornabrook, 19 66). Even James 
Parkinson in his first description of the disease claimed 
that the intellect of sufferers remained intact (Mental 
changes, 1974). Over the years, the accuracy of this 
statement has been repeatedly questioned but the reaching 
of consensus has been slow for a number of reasons.
No clear relu: ionship had been established between 
cognitive impairment and the accepted pathophysiology 
of PC, namely a dopamine depletion and basal ganglia 
dysfunction. As previously mentioned, perhaps a more 
holistic view would have offered I.he flexibility to 
include cognitive impairment as a direct result of the 
disease. PD is a syndrome of marked variability (Moehn & 
Yahr, 1967) and it is in the area of cognitive impairment 
that this variability is most clearly demonstrated. While 
some patients become severely impaired to the point of 
dementia, others remain seemingly unaffected. However, 
cognitive changes can be no subtle that without the old 
of sensitive assessment technique’s they may escape the 
attention of even the most astute clinician. Also, it 
has been difficult to separate the effects of aging and
antiparkinsonian drugs from the disease process (Barbeau, 
1972; Celosia & Wanamakor, 1972; Partin S Rinnc, 1980).
Extensive research studies have? been undertaken to 
investigate the nature find extent of the cognitive 
impairment in PI) su££erors. Unfortunately, these studies 
have included a wide variety of assessment techniques 
in both clinical and psychometric situations so particular 
care has to be taken in comparing result!? and only 
tentative conclusions can be drawn. Various components 
of cocmit-.ve functioning have been explored and while 
some researchers argue that impairment is limited to 
certain cognitive deficits which operate selectively 
(Horne, 1973), alternative research evidence indicates 
a genera 1 intellectual decline (Gnrron el a l ., 1972; 
Pirozzolo et a l ., 1982; Port in & Rinnc, 1980; Roitan & 
Boll, 1971; Riklan, Whelihan & Cullinan, 1976).
In a relatively early psychometric study, tlardyck and 
Petrinovich U965J found thaf the IQ test: performance 
(Wechslcr-Btillevuti test) of Parkinson patients was 
similar to both a chronologically much older group and 
a much youn<ier sample witli a diagnosis of organic brain 
damage. They conclude,! that i|U' changes in intellectual 
functioning accompanying PD were therefore of a fairly 
drastic nature. Thus wap, substantiated by Roitan and 
Boll (:97U  who found that, even on abilities usually 
resistant to deterioration as a result of age or mild 
diffuse cerebral damage, PD patients showed clear signs 
of deterioration in comparison to age-matched controls. 
Both these siudiea were carried out on patients prior to 
levodopa administration so the drug cannot be considered 
a confounding variable. The nature of the cognitive 
changes discussed here should be regarded as fundamental 
to PD and not I *-ea t ment-related .
Cognitive functioning involves a number of processes 
(Jordaan et a l., 1975): perception, thinking, memory
and 'earning. This classification is arbitrary as 
cognitive functioning lias an inherently unitary character 
but the above divisions provide a convenient framework 
for evaluating cognitive change in P D . I shall examine 
each process in turr
Percept i on
While other areas of sensory perception may well be 
affected in PD, most research attention has been focussed 
on visual-spatial perception. Deficits in visual-spatial 
perception and behaviour of PD sufferers have been well- 
documented (Botez S liarheau, 197 3; Bowen, Kamienny, Burns 
Yahr, 19 7 5; Herne, 1973? Lorunqer, Goode 11, McDowell, Lee 
Sweet , 19 72; Mortimer et a1., 1962; Villardi ta, Smirni,
Le Pira, Zappola & Nieoletli, 1982) . As lesions of the 
basal ganglia and disruption of the dopaminergic system 
are known to interfere with visual-spatial behaviour, and 
particularly vi sual-spa t i ,i I perception I Holler , 1982) , a 
direct link between the known subcortical disease patho­
physiology and this particular dysfunction is evident. 
However, no other impaired aspect of cognition can be so 
neatly accounted for on a structurofunctional basis.
Thinking
It appears Mint the abstract thinking ability of PD 
sufferers becomes disturbed. Patients have difficulty 
with mental organisation (Rattan & Boll, 1971) and they 
experience problems with manipulating internal symbols 
such as numerical quantities required when performing 
calculations (Portin & Rinnc, 1980). Patients have 
difficulty shifting sets (Bowen et al ., 1975; Matthews & 
Haaland, 1979; Portin & Rimte, 1980) and the concept - 
forming performance of sufferers hat; been shown to become 
disrupted to a greater degree with increasing task 
complexity (Bowen cl al., 1975). But their greatest
difficulty appears to be comprehending and analysing 
novel or unfamiliar stimuli (Loranger ct a l ., 1972).
Memory
The aspect of intellectual impairment moat readily notice­
able to both patient and observer is .« memory deficit.
All forms of memory - immediate, short-term and long­
term - are affected,with lon:-tcrm memory proving to be 
the least impaired (Boiler < • al., I'i80; Loranger ct a l ., 
1972). While the a'ility v. i,-call and utilize recently 
stored information s irpai: u 1 R1 itnn & Boll, 1971), there 
apooars to bo an "i Intv:" ■ • v..; .•.••ely wol 1 -preserved 
intellectual functi nin- ci inn of over-learned,
more impermeable, 1 ■ mq-rtana:': : .'ognitive operations 
(Pirozzolo at al., i'lR: .
Learning
This would relate ::,"vutly to the remory process. While 
little attention t, .. : - cn paid t o  t:.-j learning process of
PD sufferers as s i : : t. may be dob ,ced f*-om what has 
been said that c  . . -e r . i n "  .ving long-term, over­
learned material w i-.-n tin re: ively well-preserved
and the learning f • ,skr., pa icularly complex tasks,
would prove trou: It •: . Social .dgem- n t , for example, mny
be considered a ; i: l a  over-1 •ncd .ehaviour patterns,
but while some .''s, r • . . have ! und ' ;is to remain
functionally i: * v  , .er --t a 1 , 198''; Lorunoor ct al.,
1 972 ), other: i v  ■ a this aspect r'L cognition also to
be subject i'. ;emv nm .rmen* (Port in & rinne, 1980).
On consider: the al." ••, it in evident -hat the cognitive
impairment . !>D in c- • .'nni v e . As !'D i a  disease of old 
age, these i-l.anqen '.M be- regarded an reflecting the 
natural offeets of going. The slowing of sensory, motor 
and cognitive functi ns are cardinal functional features 
of the aging nervous system hut the slowing of thought
iprocesses in PD seems to be in addition to age-related 
neural slowing (ilnnsch, Syndulko, Cohen, Goldberg, Potv .n &
Tourtellotte, 1982). A large number of research studies 
have used aqe-mntchcd controls and have shown PD sufferers 
to consistently perform worse on measures of cognitive
functioning (Bowen ot a 1., ’975; Horn, 2974; Rcitan & jj
Boll, 19M) . We are therefore forced to assume that 
factors in addition to aginq are operative (Lorangcr et a l .,
1972) and tiivse f-ictors arc other than the restrictions 
placed on sufferers' performance.' as a result of motor 
defic'ts. It hur. been suq-jesteil that the action of 
disease phenomena is facilitated by the aging process 
(Pederzoli ot al., 198 )) so that the natural aging process 
combines with the disease process to form what may be 
termed an "accelerated aging process" (Pirozzolo et al.,
1982). This would be In accordance with Hardyck and 
Petrinovich's 1963 findings of the IQ performance of PD 
patients being similar to a chronologically much older 
<;rour of subjects .
This rapid aging process, manifesting on a functional 
level as impaired cognition, is also evident on a struc­
tural or pathophysiological level, Degeneration o£ 
substantia nigra col It; occurs as a consequence of normal 
aging but cnlJular atrophy and loss is more severe in 
PD sufferers, particularly with regard to pigmented cells 
(Mann & Yates, 1982). Evidence of accelerated neural 
aglny is not confined i <> r.ubcor t i cal structures . A dis­
proportionate number <>f pn sufferers show signs of cortical 
atrophy earlier than a'lo-mac.cheri controls (ilakira s Mathieson,
1979). Aging pos-.sibly increases the brain's vulnerability 
to the severe degenerative assault of the PD process.
Numerous at.tempts have been made to establish the preva­
lence of cognitive impairment in PD. Incidence figures 
have varied enormously with figures as low as 10% (Riklan,
1972) and as high as A 3% (Pirozzolo et al., 1982) being
cited in the literature. Besides differences in 
assessment techniques and sample selection procedure?:, 
one reason for the discrepancies may be differences in 
terminology. "Cognitive impairment", "intellectual 
deterioration" and "dementia" are used interchangeably. 
Researchers carrying out psychological/psychometric 
studies prefer the term "cognitive impairment" while 
"dementia" is used more often in clinical studies. This 
argument may be considered mere semantics but it becomes 
an issue of some importance for the purpose of clarifi­
cation. Matthews and ilaalnnd (1979) w r ote: "Use of the 
label "rtcnv a" in patients with Parkinson disease is 
often inae. .rate and misleading" (p.955). fiorne ( 2 97 1) 
also questioned the accuracy of the label being used 
generally in relation to Pn sufferers. For our purposes 
cognitive impairment should be regarded as covering the 
full spectrum of intellectual deficits/ from the subtle 
to the severe, encompassing dementia which denotes severe 
cognitive impairmv:■ .
The l-'terafure led ion' =v: fh.i' cognitive impairment in PD 
is highly prevalent, almost the rule rather than the 
exception. Martin, Loewonson, Resch and Baker (1973), 
using a clinical interview technique, found that 81° 
of patients were impaired intellectually while Piiozzolo 
efc al. ( 1982), in a particularly extensive psychometric 
study, obtained result.*: which showed cognitive impairment 
to ho as high as 9 3 . The latter study included motor 
ta-ks which could account, for the high figure but if 
the above findings are an accurate reflection of the 
situation only a minority of patients arc left intellec­
tually intact. Even these patients may eventually show 
disease-related (rather than --go-related) cognitive 
changes with Iime because oi tlie progressive nature of 
the impairment . This does not. detract from the possible 
existence of subgroups of sufferers who respond 
differently to this aspect of the disease.
The research studies suggesting the existence of sub­
groups of sufferers share little uniformity in their 
methods. Garron et al. (1972) used a self-testing com­
puterised teletyper to test the intellectual ability of 
a group of PD patients. The group excluded the significantly 
demented. Speed of intellectual functioning was measured 
and two groups omi god: a faster group and a slower group.
The slower group wore significantly older and significantly 
more disabled but had not been ill for a longer period 
of time than the faster group. Later onset of the disease 
appeared to be a determining factor in the performance 
differences.
Lieberman et al. (1979) also identified two groups of 
sufferers from which they concluded the existence of two 
different disorders rather than different patient responses 
to the same disorder. Patients were monicored over an 
eight-year period during which time they received levodopa 
treatment and repeated assessments of intellectual func­
tioning using "a simple bedside evaluation". From the 
results the researchers dcsciibod two disorders. The 
first disorder is a motor disorder with a longer and 
benign course and good response to levodopa affecting a 
younger population. The second disorder is a motor and 
cognitive disorder with a more fulminate course and 
poorer response to levodopa affecting an older population. 
Again, age of onset is a determining factor.
Boiler et al. (1980) reviewed the pathological specimens 
obtained at autopsy, together with clinical information 
including mental status data, of twenty-nine PD patients. 
Unfortunately, they use i tie term "dementia” very broadly 
so nuances of cognitive impairment are difficult to 
extract from the data. However, 55% showed evidence of 
"dementia" and most of these patients (75?) had patho­
logical changes consistent with AD. Two forms of PD 
were suggested: the first is PL with dementia characterised
pathologically with subcortical PD changes and cortical 
AD changes. The second is PD without dementia with 
pathology limited to the basal ganglia. Unfortunately, 
age of symptom onset is not given.
Mortimer ct a l . (1982) examined presenting motor 
symptomotology in relation to psychometric measures 
of neuropsychological functioning. Two forms of PD 
were implied: one with predominant tremor and relatively 
intact intellectual functioning and another with more 
marked bradykinesia and neuropsychological impairment.
Age of onset was not an Influential m o t o r . Mortimer 
and his co-workers comment that treatment (levodopa) 
may have masked an even stronger relationship between 
motor and cognitive functioning than was shown.
The effects of levodopa on cognitive in.panment were 
initially extremely encouraging. Levodopa seemed to 
have an "awakening" effect (Cot zias et al ., 1969) 
immediately improving cognitive functioning. Researchers 
marvelled at its effectiveness. "Levodopa increases 
overall brain efficiency such that one of its most 
specific effects at the cogniti-.-o level may be improved 
functioning at the most abstract and verbal level" 
(Beardsley s Pulofti, 1971, p. 150). Others viewed 
levodopa1s effects with more caution arguing that levo­
dopa merely improved "attention span" or "vigilance" 
without increasing the patient's overall cognitive 
ability tBowen et a 1., 1975). As the subcortical arousal
network is dopaminergic, increased activation or arousal 
would be an expected effect of levodopa administration 
(Riklan et a l ., 1976).
Research studies have been carried out at varying stages 
of levodopa treatment. Beardsley and Puletti (1971) ' 
showed levodopa to increase full scale IQ test scores 
of PD patients by as much as !0 points over the fiist
6 months of treatment. Halgin ot al. (1977) compared 
the recent memory performance of a short-term levodopa 
group (22 months or less) with a longer-term group 
(40 months or more) and their results indicated that 
initial improvement was temporally limited. They 
concluded that while cognitive functioning significantly 
improved following levodopa treatment it failed to reach 
the level of normal age-matched controls and after 2 
years of treatment showed a subtle regression to prc- 
lovodopa levels.
Riklan et al. (1976), in a long-term study, showed no 
significant difference or progressive deterioration when 
he compared the cognitive functioning of sufferers after 
5 years' treatment to sufferers receiving no levodopa and 
short-term users (1 month to 3 years) but their performance 
remained significantly worse than non-diseased controls. 
After 8 to 10 years of levodopa treatment, Portin and 
Rinne (1980) noted highly significant deterioration in 
motor, visual-spatial, verbal and memory processes 
following marked improvement in the same patients after 
2 to 3 months of treatment. The reasons for this waning 
influence remain hypothetical, as discussed in Chapter 2.
There is no type of cognitive impairment specific to PD 
(Horn, 1974; Hnyoux cl al., 1983). Deterioration is of 
a general and progressive nature and few escape its 
effects. The literature includes several references to 
the variable response of sufferers to the Parkinson 
dementing process which appears to be of combined cortical 
and subcortical pathological activity. The factors 
contributing to the variable response remain to be 
establtshed.
CHAPTER 5
THE ASSESSMENT OF DEMENTIA
Dementia presupposes a significant deterioration from a 
higher level of intellectual functioning. The assessment 
of dementia must however take into account "normal" 
decline or deterioration, which is part of the general 
organic proccss of aging, and "abnormal” doclinedue to 
other factors. An individual can only be said to show 
signs of mental deterioration when, in comparison with 
his own previous functioning, there is a significant loss 
of ability and the decline is greater than the changes 
expected for a person of that age (Wechslcr, 1958).
Whan distinguishing between a norma] decline in human 
abilities and abnormal loss or impairment,the distinction 
can he arbitrary a,; if is not always oasy to indicate 
where one ends and the other begins. However, a marked 
and disabling loss at any aae must be regarded as a 
definite sign of impairment (ivcchs lor, 1 958) .
A precise measure of the degree of mental deterioration 
demands that I he previous level of functioning is 
accurately established. This is rarely possible as it is 
only once the deteriorating process is in progress that 
a reason for assessment arises. Estimates of previous 
functioning levels may bo gleaned from interviews with 
family and friends together with information regarding 
educational and career background. At best these must 
remain estimates as they are subjectively formulated.
The ideal procedure for monitoring the Parkinson dementing 
process would involve predicting PD. This would allow us
to earmark those patients likely to contract the disease 
and then, by systematic and repeated assessment, to 
monitor changes in intellectual functioning over a period 
of time prior to symptom onset and during disease pro­
gression. Current longitudinal research, such as Portin 
and Rinne1s 1980 study which evaluated patient functioning 
over a 10-year period, is only able to measure disease 
effects onco the disease is in progress and therefore can 
only partially reflect deterioration because no accurate 
functional measure prior to disease onset exists.
When planning to assess PD patients for dementia, we were 
faced with a number of alternatives in assessment tech­
niques . The first is the clinical interview which is 
designed to yield an indication of cognitive functioning 
including responsiveness, attention, language, memory, 
perception and reasoning (Heilman S Valenstein, 1979).
Horne (1973) writes: "The assessment of dementia can be 
simply a subjective, clinical evaluation, which is, 
unfortunately, most often how it is made in studies on 
Parkinsonism" (p.548).
There are inherent disadvan tagcs in assessing dementia 
by clinical interview oven when the interview data are 
obtained in a controlled format as in the Mental Status 
Examination, Meyer (1983) writes: "The examination 
contains the? weakness of all data obtained from interviews: 
there are few or no statistical or normative standards 
for the obtained responses on which to base a communicable 
inference and an eventual diagnosis. Examiners are too 
often left to develop their own idiosyncratic notions of 
v.'hat a certain response means" (p. I) . These disadvantages 
must be acknowledged particularly when more subtle 
differences in cognitive functioning between patients are 
at issue and quantitative measures of these differences 
arc required.
] The seccr.d j v: v.p zochr.iq^es i-.' ill ace fcr 33sessir..j
! der.er.tia are l.ib'.'racory Gxari-uti'r.s, such as --he CT
scar. a:-.d the EEG, -ind the physic.xl. exarxnaticr. which 
ir.vestiaatcs the cr nr.:al r.erves, ".s-.Ty and rotor
• systers 'Hcllrari i Valins toi:*., t 3'9'1 . These to-hr.iques
provide i r. f o rr'.a 1 1 ; r. ro-’ardi r.’ no uro logical f u:-.c 11~ r. ir.-j 
and status. They car. identify r.ourclc.;.cal correlates 
of derer.tin, hut our c:'r.ct?r:: is the patient's actual 
functional status. Per <_5>:a~r-le, net all dcr.entod 
vatients shcv si'-rr.s cf c t u 1 atrorhy ''Fe-irce i Pearce, 
19*5- anu net all ratien-5 with cortical a.ronhy are 
funct 1 2 n.1 l ly dor'.entc-d ; V : 1 lur ot al . , 193 ? 1 . These 
instrur^r.ts h a w  :.uh di runts; i j valu-^ hut, while they 
can rrcvidc valuable sui-.i.le-.ontary r.cur:'!:Jical infcrr- 
31 ion, their value as irdicat rrs 3 : cognitive func ticnin: 
is iiritod.
Because the .jssossr.-.’r.t ?t ier ent ia involves a sarplinn 
cf bohavi: ur within the asscsjrcnt situation frcr which 
certain deducti.Tna are ndc- r-_ rdir. : the patient' s 
neneral funoticnal status, the r o n t  cf an assasszer.t 
technique rests on h'w accur3t-?ly -.--oral funoticnal 
status ran to r.educed fror. thg results. Thir can be 
dene rest use: -lly by carryir.M rut arnropriate psychc- 
ratrio tests, the third lasosaront alternative available 
to us. The: value f rsychor.etric tochni-’ucs lies in 
their objectivity of star.dardised r a t i m  r.etheds and 
ad^.in istraMve nr^ce lur^s. They can iet.ect subtle 
in ner.tal functionin',' 1 : n : Lo E re the?-1 changes have 
disor xmised behaviour that dotorloration is obvious ■ 
all rWech.= ler, I 9' S 1 . Also, ::nychor;etv ic instruments 
provide -runcitat l w  i^urca coi/ntive functionin' 
which are cenduci v? t i'.o an i ly - 1  .= di f :'o venc
Assessirvj subi^ct.- v;!v V. iV" .1 rotor disability, • 
psy rhoret: i _■ in^Turent like the XAiy ;xi: 1 oh xas
the present study), presents a problem in that the pro­
cedure includes a performance scale involving timed items 
which measure the speed of motor-related intellectual 
functioning. Visual-spat1al per '-ption and behaviour 
play a strong role in these performance tasks and PD 
patients are particularly disabled in this area as a 
direct consequence of disease patholouy. Villardita et al. 
(1982) write: "The visueperccntive deficits ... of 
parkinsonians cannot be considered as a mental deterioration 
index" (p.il'-'O. because of their meter and visual-spatial 
deficits, PD patients a re at a double disadvantage when 
faced with performance tash', so the use of these measures 
m  the assessment of c.gnitive functioning in PD must be 
invalid. This view is in accordance with Villardita and 
his co-worker.-; who suoyost the exclusion of visuoperceptive 
and spatial tests and the inclusion of appropriate verbal 
tests. Performance tasks do not measure a different kind 
of intelligence. Rather, they provide a different measure 
of the same in tel 1m e n c v  underlying verbal tests (Wechsler,
19 56 1. Also, scores obtained on the Information and 
Vocabulary subtest:- from the WAI.d correlate most highly 
with total IQ test scores sc they offer suitable tools 
for assessing intv11"Ctual functioning m  PD.
In addition to verbal sub tests from the l-.'AIS, the present 
study included abbreviated scales from Luria's Neuro­
psychological Investigation (Christenson, 1975). These 
scales were included as they are particularly sensitive 
to inletlectual impairment.
CHAPTER 6
METHOD
t'orty-throc white subjocts (26 ma'.us and 17 females) were 
selected from thr outpavients attending the PD Clinic at 
the Johannesburg General Hospital. Participation in the 
study was Limited to iona-tern sufferers of idiopathic 
PD who had not undergone surgical intervention for symptom 
relief and who wore currently receiving Levodopa therapy. 
Treatment dosage had been individually determined for 
each patient over time in order to afford maximum thera­
peutic effect with a minimum of sido-cffects. Final 
subject Hulcction was then determined simply by the simul­
taneous availability of bot"h tester and patient.
The ages of the patients at testing ranged from 47 to 86 
years (M = 6 8,21; SD = 8,93). The duration of illness 
ranged from 3 to 36 years (M = 11,46; SD = 5,66) calculated 
from symptom onsci-. Age at disoasc onset ranged from 
21 to 77 years (M -- 56,72; SD = 12,13) .
Of our forty-three patients, four (9i) had no formal 
education, five (2 1 ?,) had some primary school education 
and thirty-four (79%) had some high school education, 
thirteen (30%) having passed matric. Twenty-two patients 
{52") had some form of post-school education or training. 
Only one patient had a university degree.
CHAPTKR 6
METHOD
Subjects
Forty-three white subjects (26 males and 17 females) were 
selected from the outpatients .attending the PD Clinic at 
the Johannesburg General Hospital. Participation in the 
study was limited to long-term sufferers of idiopathic 
PD who had not undergone surgical intervention for symptom 
relief and who were currently receiving levodopa therapy. 
Treatment dosage had been individually determined for 
each patient over time in order to afford maximum thera­
peutic effect with a minimum of sidc-effects. Final 
subject selection was then determined simply by the simul­
taneous availability of both tester and patient.
The ages of the patients at testing ranged from 47 to 86 
years (M = 68,21; SD = 8,93). The duration of illness 
ranged from 3 to 36 years (M = 11,46; SD = 5,86) calculated 
from symptom onset. Age at disease onset ranged from 
21 to 77 yearn (M =•• 56,72 ; SD = 12,13) .
Of our forty-three patients, four (9%) had no formal 
education, five (2)t) had some primary school education 
and thirty-four (79?.) had some high school education, 
thirteen (30%) having passed matric. Twenty-two patients 
(52%) had some form of post-school education or training. 
Only one patient hud a university degree.
*The premorbid careers cf the patient sample were diverse.
Seven patients had held executive/managerial positions, 
eleven were involved in sales, six were tradesmen, three 
were employed in the accounting field, seven were secretaries, 
two were involved in publishing and three were housewives.
The remaining five patients included a music teacher, a 
nurse, a customs officer, a storeman and a truck driver.
Only two patients were still working at vhe time this 
study was undertaken.
Thirty-nine patients (91%) were married. Thirty-five of 
these patients had children.
Materials
A battery of neuropsychological tests was compiled to assess 
the cognitive functioning of the patient sample. The 
following tests were included in the battery:
A . Subtests from the South African version of Wechsler’s 
Adult Intelligence Scale
The WAIS subtests arc extremely well-documented and 
well-known. Therefore, the four verbal subtests 
selected for use are only briefly described here.
Information
This is a measure of the general information absorbed 
from the environment by the subject (Zimmerman 5 Woo- 
Sam, 1973). It reflects educational background, 
intellectual curiosity and rending habits. Motivation, 
verbal comprehension and rote memory all play a role 
in the subject's performance. Information is a "hold" 
test, involving cognitive abilities relatively 
invulnerable to mental deterioration (Wechsler, 1958). 
Deterioration must be very severe to have any profound 
effect on the storage of information (Zimmerman & 
Woo-Sam, 1973).
ir
Slmilaritioii
Similaritiesi is a test of concept formation. It 
measures the ability to generalize, abstract and 
identify rpL«itionships. "Concept formation is one 
of the aspucts of every tbouqnt process, and...it is 
one of the main channels through which maladjustment 
encroaches on intellection" (Rnppaport, Gill & Schafer, 1945, 
p.iOO). It Ls a "don't hold" test, involving cognitive 
abiLitios vulnerable to mental deterioration (Wechsler,
1958).
Digit Span
This is a test of the immediate recall of auditory 
symbols. In addition to immediate memory, it measures 
attention and freedom from distractability. A marked 
fallimi off of memory span is often one of the 
earliest indications of mental impairment (Wechsler,
1958^ . It is a "don't, hold" test.
Vocabulary
Vocabulary is a particularly good measure of general 
intelligence. It involves rote memory to some extent 
but is a strong reflector of educational background 
and life experience. "This subtest is one of the 
least vulnerable to pathology of any kind and is 
generally felt to provide a reliable estimate of pre- 
mo rb id functioning in a person suspected of suffering 
intellectual deterioration" (Zimmerman & Woo-Sam,
1973, p. 117). Vocabulary may tend to fall with 
deteriora ion but will remain the least impaired of 
the cognitive functions (Rappaport et al.,1945).
It is o "hold" test.
13. Abbreviated forms of Luria's Neuropsychological 
Investigate on (Christensen, 1975)
The Luria scales arc generally used as a diagnostic 
tool in the assessment of neuropsychological status.
*Although nc normative standards arc available on these 
scales, they -.ave boon included here because their 
sensitivity to coqni Live impairniGnt lias been demonstrated 
within the clinical situation. The tv.l lnw iny subscales 
were used in nbbroviatod form (see Appendix I):
Memory St-.ih-
A numL'cv of assessntDiU Lvclmiijuos arc used to measure 
the different complex [Vk -p i h  of immediate ludi tory
Investigation of the I.vainin«i Procesa (ix.c-; i): The
subject is prossiM-itcd with a series of seven words and 
the nuniber ,:if wor-Js rcrvmLi'r!?d is noted after each of 
five trials. This t hr way in which the
volume of retained material increases during the 
learning process (Luria, I'Hif.) .
Investigation of the direct impression of traces 
(items 2, _i 4 ..id "0: The ub ject. of this investigation
is to determine to what vxtei.; the patient is able to 
preserve direct tracer, or after-effects left behind 
by verbal stimuli. The subieet is (-resented with 
words wlv ch he is to lu to remember. lie is then 
presented vith verbal or visual distractions in the 
form of additional words, st. ntences or picture cards 
which he is also asked to remember. The subject is 
then asked to recall the word-; presented initially.
Rocal1 is then a measure of the inhibitory effect 
produced by the distracting materi.il (Luria, 1966) .
Investigation of logical memorizing (item 6): The
subject is asked to remember seven words with picture 
cards presented as memory aids. These cards do not 
depict the direct meaning of the wore but lather 
demand that the subject establish a chain of meaning 
between word and picture.
Receptive Speech Scale
Receptive speech is the perception ci speech received 
from an external source and the decoding of the speech 
symbols (Luria, 1973). It refers to the perception 
of speech sounds, the understanding of the meaning of 
words and phrases, and finally the understanding of 
consecutive speech (Luria, 1966).
The investigation of the understanding of logical- 
grammatical structures assesses the following aspects 
of receptive speech:
i) the unders tending of object names and the
grammatical constructions expressing relatior - 
ships In-tween objects (items 1, 2 and 3) 
li) the understanding of constructions using the 
attributive genit'.ve c.iun (items 4 and 5) 
lii) tie understanding of prepositional constructions 
involving spatial and similar relationuhips 
(items 6, 7 and 6) 
iv) the understanding of comparative constructions 
involving mental inversions (item 9) 
v) the ability to analyse phrases of complex 
grammatical structures (item 1 0 ).
Expressive Speech Scale
Expressive speech benins with an idea which is coded 
into a speech scheme with the aid of internal speech 
and is converted into narrative speech based on a 
1 generative1 grammar (Luria, 1973). The items included 
investigate facets of narrative speech which constitutes 
a vital part of the study of the most complex functions 
of expressive speech activity (Luria, 1966). The 
items measure the extent to which the patient is able 
to operate complex systems of grammatical expressions. 
Subjects are asked to complete sentences presented 
with words missing (item 1), to construct sentences 
including words presented to them (item 2 ) and to
construct sentences by rearranging words presented in 
a disarranged order (item 3).
Reading Scale
Reading is a form of receptivc speech. It involves 
the visual perception and analysis of written 
linguistic symbols and the comprehension of what has 
been written (Luria, 1966) . The reading investigation 
includes the reading of a simple sentence (item I), 
the reading of sentence's not conforming to their 
anticipat~d meaning (item 2) and the reading of a 
complete text (item 3) which demands the comprehension 
of the relationship of one sentence to another rather 
than tho discrete understanding of individual w o r d s .
Writing Scale
Both reading and writing are acquired skills demanding 
special training which is in contrast to spoken speech 
which proceeds automatically (Luna, 1966) . Writing 
is a form of expressive speech. It begins with a 
thought which i& coded into phonetic structures of 
internal speech which in turn leads to the construction 
of the written symbols. The writing investigation is 
designed to analyse the state of the various levels 
of writing with the items selected measuring the 
following a#poet#;
i) the patient's ability to perform the fine 
movements of writing (item 1)
ii) the quality of the patient's ability to write 
from dictation (i terns 2 and 3) 
iii) the patient's capacity to devise a deliberate 
plan of writing activity by decoding internal 
speech into a system of written signs (item 5) 
iv) the patient's functional writing ability to 
execute a task from everyday life (item 4).
C . Phe Harris Subsc.) le (Sub jurt i vu Deprc-ss ion) of the 
Mi; '? Depress ion He.: io (Graham, I')77)
This ji . <m !o war. dev: r.vd by umierl.ik i ii'i a coritx’iit 
analysis > thy items con:;! it.utinq the MMVI dupression 
scale and v>: ictinci t Iioho lU-ms mcasurim; ;>ul,j«jctive
depression. T r  Harris sut seal u contains 32 items.
It is shorter .uni 1 vss cumhfr:;ome i - ■ administer than
the original MMI’l •.it-i'i ossion :sc,il v (GraL.im, 1977) .
Procedure
Subjects were in formed tn.it a 1 u<iy of the effects of PD 
was being c>. rviuctod .uui they were ix-.-fuc-stpd tn participate. 
The nature ami ::uthod '•estinq wer<’ t.'xuLiincG to them 
and all subjects willin'.; -o-ofx-im t,
A team of pos t-gr^uuui e ; ■ :v s i .. i- ■: ' s , well-trained
in the administration vf t lie • .'Kt i " i  : a 1 , carried out
the testing. The- tester:: we re instiuc. : to fully record 
their subjects' ret,ponPc-G . All scoring was then v.:ider- 
t. i>en by the writer to ensure s d  rin" uniformity.
Each sui^j • w is ui'i i vi dua 11 y test. 1 in a quiet, well-lit 
room at the J.-.,. mmr.bui ) Guner.il I!'.;-., i f a 1. Testing took 
placc in the mid-nw t :i i tv; 'hiring a : nt ! ne visit to the
PD Clinic. Kach testii.t - ":i:|wn las t ed ap[>roxi mate ly two 
hours with frequent rest p e r : < d;; l,e i ng offered to '-.he 
subjects in an effort to avoid t ii .ng them.
The session commenced with the gathering of biogmphical 
details. The following were noted:
1. name, present ag e , sex
2. marital status, number of children
3. educe Lonal background including post-school training
4. premorbid career and present ei.-nloyment status
5. history of PD including age at which onset occurred, 
duration of illness and present treatment.
The tests were then administered in the following order:
A. WAIS Subtests
1. Information
2. Similarities
3. Digit Span
4. Vocabulary
B. Luria Subscales
1. Memory
2. Receptive Speech
3. Expressive Speech
4. Reading
5. Writing
C. Harris Depression Subscale
1
eeaSfi
CHAPTER 7
RESULTS
Descriptive statistics for the demo.n aphic data and test 
scores are presented in Tabic 1 below.
Means and Standard Deviations for Patient Variables 
and Test Scores
Demographic Data
Present Age 68,21 8,93
Duration of Illness 11,49 5,86
Age at Disease Onset. :2,13
WAIS Sulitests
Information 1 3,49 4 ,20
Digit Span 11,12 2,42
Similar!ties 14,51 4,59
Vocabulary 19,26 7,98
Luria Subscales
Memory 7,5E 3,63
Receptive Speech 2,23 1,78
Expressive Speech 1 ,14 1,10
Reading 0,63 0,95
Writing 2,56 3,48
Depression 13,77 5,52
Pearson product-moment correlation coefficients were 
computed to investigate the nature of the relationship 
between the four patient variables and the tost scores.
The complete correlation matrix is presented in Appendix 11. 
Sections have been reproduced here for discussion purposes. 
Table 2 shows the intercorrelat ions between present age, 
duration of illness, age at onset and sox.
Table 2
Pearson Product-Moment C<■ rre 1 at. 
between Patient Vnri
ion Coefficien ts
Present
of illness Onset Sex
Present
1,0000
Dura tion 
of Illness -0,3100" 1,0000
0, 88 87*** -0,7)98*** 1,0000
0,0904 -0,1831 0,1617 1,0000
>'< p<0,05 
*** ">0,001
An examination of the r•elationships between patient
variables showed a significant correlation between present 
age and age at onsoi (r=0,8887; p<.0,001). Present age 
showed n significant negative correlation with duration of 
illness (-=-0,3160; p<0,0r>). A significant negative 
correlatior also emerged between ago at onset and duration 
of illness (r=-0,7V>fi; p<f0,00l). These results indicate 
that the older put ion Is had experienced disease onset at a 
later age and had been ill for a shorter period of time. 
The converse would apply io the younger patients.
The relationship of sex to the other patient variables was 
not significant.
T T
Intcrcorrclations between patients variables and test scores 
are presented in Table 3. It should Ja noted rh.it the Luria 
Subscnlos are nogatively sc-orc'jK___________________ ______________
BklSL-l
Irt.crcoi-! 1 at inns between Patient Variables 
nd Test Scores
Present Duration Aqe at
Tests Age of Illness Onset Sex
Depression -0,04 U) -0,0707 0 , 0 0 2 C -C,0 35 3
In formation 0,0085 -0,4399** -0 , 1 1 8 1
Digit Span -n, i'Hi: -0,14 33 -0,0767 -0,0194
Similar!tics -0, 3154 3-'* 0,1074 - 0 , 3 3 4 8 * 0,0242
Vocabu' -0,4 r>>')8;< * * -n,02C? -0,3226* 0,1547
Memory 0 , J 2 3 7 n,0367 0,1469 -0,130"
Rce. Speech 0 , I 6 J 8 0 , 0 n 7 0,0900 -0,1067
Exp. Speech 0 , i>r)4 )*** -0,0991 0 , 3 2 9 4 * * * -0,1034
Reading -0,1612 0,0675 -0,1660 0,0165
Writing n, N I H 0,0762 0,0675 -0,2004
•'< p<(j, 05 
** pvO/01
**>'< p<0 ,001
Present aye showed a s igni i'ic\uu nvgol ive correlation with 
scores on Information (r - >1, r> 21; p-x'1, 001) , Similarities 
(r=-0 , 384 3 ; p<0 ,0 1 ) , '/or iht;! .iry (r--0 , A 568 ; p<0 ,001) and 
Expressive Speed: fr 0, (i'3'1 : ’<<0, 001) . This indicates 
that the older the patient, ? liv worse his pvrformance on 
these sub teii t;; pro veil t.o bo. at (’nset slurped signifi­
cant negative correlations wi ': Miese .siil i i-.itInformation
(r=-0 , 4 399 ; pcO , 01 ) , S imi l.iri i i r,,: ( r-' -i', 3 > !8 ; pvO , 05) , 
Vocabulary ( r--0 , '.2 2r>; p<0 ,05) .imi i;xv-i I'SSive Speech 
( r = 0  ,5294 ; p<0, 0 0 1 1 . Th e o l d e r  t in- z>,n j m t  wn.<; a t  d i s e a s e  
o n s e t ,  t h e  lo w e r  lie : ' o re i l  on  t h e s e  s u b t e s t s .
Test performance showed no si ijii.if leant i e 1 at ionsliip to 
duration of illness or sex. The relationship between
depression and the four patient variables was not sig­
nificant .
An iterative principal components analysis with v;'"'iinax
rotation was conducted oa all Jc;;l scores in order to
determine the nati're of the underlying dimensional 
structure of these measures. The component matrix is
presented in Table -1.
T u W e _ 4
V.irimux Rotated Component Matrix:
Lou lings of Test dvores on Components 1, 2 and 3
Te#cs
Component
1 3
Informal ion 0,83C80 -0,14493
Digit Spar 0,24566 0,93093 -0,20222
Similarities 0,63563 0,25746 -0,45506
Vocabulary 0,86649 0,12516 -0,22225
Memory -0,35168 -0,43934 0,41025
R c c . Speech -0,46394 -0,23476 0,52712
Exp. Sr.,each -0,70187 -0,31150 0,06749
Rending -0,04 356 -0,10340 0,66792
Writing -0,41-195 -0,28762 0,51012
N ote. A salient loading wan ."then as 0,4 or marc.
The first two component s were associated with an eigen­
value of 5,4922 and 1,2577 respectively. The third 
component produced an eigenvalue of 0,6595. Although 
Component 3 was not significant in terms of Kaiser's 
criterion, it was included in all subsequent, analyses as 
it was considered to be of statistical interest. Compo­
nent 1 accounted for 7 4 , 1 of the variance, Component 2 
for 17,0% of the variance and Component 3 for 8,9% of 
the variance.
*Table 5
Summary of Tests Loading oi 
Components 1, 2 and 3
Component 1 
"Intellect"
Component. 2 
"Memory"
Component 3 
"Linguistic Skills"
Information (W) Digit Span (W) Receptive Speech (L)
Similarities (W) Memory (L) Reading (L)
Vocabulary (W) Writing (L)
Expressive 
Speech (L)
Ntte. w - K.MS Subtest, I. = Luria Jubseale.
Cc.nponimt I ruflc.-1 s •jonnv.il intellectual functioning and 
was therefore labellcu " Iniellvci11. Information, Vocab­
ulary and Similarities are all good measures of general 
intelligence or Correlation figures with G for the
older age group (over 60) .ire given as 0,73 fur Information, 
0,65 for Similarities and 0,66 for Vocnbularly (Zimmerman & 
Woo-Sr.m, 1971).
Initially, it was surprising that Expressive Speech loaded 
so strongly on Component l. However, an appraisal of the 
Expressive Speech test items indicated that processes of 
narrative speech were measured. As noted earlier, narra­
tive speech constitutes tlie most complex functions of 
expressive speech activity (hurl a , 1966) and must be con­
sidered a highly "intellectual" form of speech demanding 
analysis, synthesis and conceptual ability. Por'ormance 
on these items would, therefore, also reflect general 
intellectual functioning.
All four of the subtests loading on Component 1 showed 
significant correlations with present age and age at 
onset as noted previously (Table 2).
Component 2 was label]cd "Memory". A h both subtests 
contributing to this component measure immediate auditory 
recall (albeit different facets of this function), the 
basis for their common loading on Component 2 is clear.
In attempting to interpret the common construct underlying 
the subtests loading on Component 3, an analysis of the 
tests' items revealed that they weti all reflecting "low" 
or habitual forms of speech n c t i v U y  as opposed to items 
selected from the Kxpros.aive Speech scale, for example, 
which measured "high" or intellectual speech forms (Luria, 
1966) . The items e. ns I. 11 ut i ne the subtests loading on 
Component J may all be regarded as the least complex, and 
generally the least intellectually demanding, of all the 
items included in the s^udy. Also, there is a strong 
element of trained speech activity underlying the three 
subtests although certain Receptive Speech items do 
demand abstract reasoning ability. It was decided that 
Component 3 was Irest defined by "Linguistic Skills" end 
was given this label.
The three cumponenfcs were each subjected to unidimensional 
hierarchical cluster analyses. The purpose of this 
investigation was to determine whether or not the patient 
sample was heterogeneous in composition as reflected in 
differential test performance. Any clustering activity 
would therefore be based on test score differences. The 
amalgamation histories of each analysis are presented in 
figures l, 2 and 3,
Examination of the amalgamation histories for Intellect 
(figure 1) and l.ingulsitie Skills i figure 3) indicates that 
discontinuity in the amalgamation distance was produced 
by small mergers huh no reliable evidence of major under­
lying clusters was demonstrated. The amalgamation history 
of Memory (figure 2) shows more promise of cluster form­
ation. On visual o.xamj nnf ion, three clusters appear ,o 
exist and they were labelled Group 1, 2 and 3 respectively.
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Table 6
Means and Standard ueviat ions of Patient Variables and 
Scores of the Three Groups Emerging from the Cluster 
Analysis Performed on the Memory Component
Group
Variable 13) (n=I9) (r
3
1=21)
-ID « §5 M SD
Present 66,69 7,27 66,52 7,41 72,91 10,83
of Illness 4,30 12,63 7,26
11,36 3,63
S X e f
-f.,77 36 3 3,M  12,30 60,64 14,90
Scores in, 15 1,96 2,:>c 1,82 -3,27 1,21
The differences between the patient groups constituting 
these three clusters were explored. The means and 
standard deviations of present age, duration of illness, 
age at onset and patient scores were calculated for each 
group and are presented in Table 6. Table 7 shows the 
_t scores generated by the differences between group 
means for each of the pat innt variables. h significant 
difference between irhe three groups was demonstrated 
with regard to test scores. The groups were identified 
as "high" (Group 1 > , "moderate" (Group 2) and ’’low"
(Group 3) scorers. No other patient variable produced 
significant bctwecn-qroup differences to further 
differentiate the three groups. On inspection of Table 6, 
the " low" scorers appeared to be older at testing and 
older at onset, but. no significant, results emerged.
The three clusters maintained separate identities until 
the last two steps of the analysis. At this point,
Group 2 and Group 3 were amalgamated to form one group 
and at the final step, Group 1 was amalgamated with the
T a W e _ L
Differences between Group Means of Patient variables and 
Scores of the Three Groups Emerging from the Cluster 
Analysis Performed on the Memory Component
Variable Groups t
Present Age T vs 2 0 , 0 6 2 2
5 vs 3 1 , 6 0 1 4
vs T 1 , 8 4 7 5
Duration of Illness 1 vs 2 1 , 1 7 0 3
2 vs 3 0 , 8 3 9 7
3 vs T 0 , 5 2 4 2
Age at Onset 2 v s 0 , 6 9 1 9
2 v s 3 0 ,  2407
2 vs T 1 , 2 9 3 4
Scores 1 vs 2 1 0 , 3 2 2 6 *
5 vs 3 1 8 , 9 3 0 7 *
3 v s
* p<0,00l
newly formed group without any increase in amalgamation 
distance. Homogeneity of the patient group was therefore 
established.
The three components were then combined and subjected to 
a multidimensionai hierarchical cluster analysis. The 
amalgamation history is presentcd in Figure 4. The smooth, 
continuous increase in amalgamation distance shows no 
reliable evidence ot underlying clusters.
In order to investigate the predictive power of the patient 
variables, stepwise multiple regression analyses were 
carried out on each of the three components. Present age, 
duration of illness, ago at onset, sox and depression acted 
as predictor variables. Only main effects were examined. 
The inclusion procedure which operated for these analyses 
is presented in Table 8.
Inclusion T o c c d u r e  for Stepwise 
Multiple Regression Analyses
Predictor Hierarchical Inclusion Stepwise
Variable Order Inclusion
Age at Onset
Duration I Yes
of Illness
Present Ago
Depression 2 Yes
Multiple Regression of Intellect on present age, duration 
of illness, age at onset, depression and sex
A summary of the independent variables entered at eacn 
step of the analysis, together with R2 , the coefficient 
of determination, change in R" and related F values is 
presented in Tible ‘i.
Multiple Regression of Intellect on Present Age, Duratio 
of Illness, Age at. Onset, Depression and Sex
Predictor Variable RZ P« Change in R^ F b
Age at Onset 0,15
Duration of Illness 0,27 7 , 3 0 * * 0, 12 6,34'
Present Age 0,35 7,09* 0,09 5,15*
Depression 0,41 6,58* 0 , 0 6 3,62
5 , 2 0 * 0,00 0,23
test of the null hypothesis that R =0 (df=k,N-k -1) 
• test of the null hypothesis that change in R 2=0 
(df=l,N - k  - 1)
Inspection of the I’11 values in Table 10 indicates that 
each independent variable was a significant contributor 
to Intellect. However, the significance of the individual 
contributions altered once the influence of the other 
predictor variables was taken into account, as shown by 
the F values.
Age at onset was •'nfcred into the regression equation 
first and explains 15;, of variation in Intellect 
(F(1,4l}=7,32) which is significant beyond the 0,01 level. 
Duration of illness was entered at step 2 and contributed 
a further 12:. to variation in Intellect (F (1,4 0)=6, 34; 
p <.0,05j . However, once present age was entered at step 
3, age at onset and duration of illness were no longer 
significant. Present a ge’s contr’butior vo change in 
R" was significant beyond the 0 , 0 1  level IF(1,39)=5,1 5) . 
Once all the predictor variables had been partialled o ut, 
present age remained the only significant predictor of 
Intellect (F(I,J7)=4,82; p 0,Oh) .
Because of the multicoline.n ity between these three 
time-related variables, the interpretation of these 
results is complex. Present ago, dotation of illness and 
age at onset are all heavily confounded variables because 
of their close relationship. U. should lie noted that 
it is difficult to examine the effects of one of these 
variables without, indirectly examining the effects of the 
others. Therefore, those results cannot simp1y be inter­
preted as present age alone being the decisive variable 
in determining the performance on Intellect. The 
influence of the other timc-rclatod variables cannot be 
ignored even though their unique contributions wore not 
significant.
The relationship between Intellect and present age was 
negative (r=-0,5353). Therefore, the older the patient, 
the poorer his score on Intellect proved to be.
Tabic 10
Multiple Regression of Memory on Present Axje, Durivtion 
of Illness, Ago at Onset, Depression and Sex
Predictor Variable F"1 Change in R‘! Fb
Age at Onset 0 , 0 1 0,43
Duration of 11 Incss 0 , 0 6 1,27 0 , 0 5 2, 10
Present Aqc 0 , 2 0 3,28 0,14 6,91*
Depression 0,27 3, 50 0,07 3 , 5 2
Sex 0,27 2,74 0,00 0,05
test of the aull hypothesis hat R"“ 0 (df=k,N - k  - 1)
h - test of the null hypothesis (hat change in R2=
(df=l,N - k - I)
The prcdictor variables; in concert explained 41" of the
variation in Intellect.
Mult iplo renress ion of Memory o n * '-eruint a qe, duration of
Illness, age at onset, depress ion and sox
As Table in shows, t.lie indc'pendont variables explained 
2 7 of variation in Memory . The only cun I ributo.- to 
produce a siynj f irant: change in r “ was present age, 
accountiny for 14V. of the explained variance (P (1, 39=6 , 9 I ; 
pCO.OS).
The contribution of a<;e at onset ‘.o vnri;-'i-’T in Memory 
did not emerge nn signi ficant uni 11 prese1 • i:e entered 
the equation at slop 3. Once present age was held 
constant, age at. onset became significant (F (i, 3" 1 =5 , 5 J ; 
p <0,05) . Age at onset's unique contribution to variation 
in Memory rema Lru'rl s M  n 11 Irani I]-' (1 , 17 ) = r>, I 4 ) beyond the 
0,05 level when all Liie other predictor variables had
Vbeen parfciaLled out. Jiowcver, present age emerged as 
the strongest predictor of performance on Memory 
(P(1,37)- 6,63; p <0,05) . Memory was unaffected by 
duration of illness, depression and sex.
An examination of the relationship between Memory and 
the two significant predictors indicates that as age at 
onset increased, Memory scores decreased (r=-0,1016) 
and, likewise, as present ,i<rc increased. Memory scores 
decreased (r=-0,2404). Therefore, the older the patient 
and the later disease onset occurred, the poorer the 
patient per formed on Memory .
M ultiple regression of Linguistic Skills on present ag e , 
duration of illness, age at onset, depress!on and sex
An examination of Table 1 1 reec.i In that present age and 
denreasion both produced significant changes in R? .
Present age contributed 28t (P(1,39)=15,67; p<0,01) and 
depression contributed 1 2 ' (F (1,3 8)= 7,4 1; p<0 ,01) of
the 4 2i of explained variation in Linguistic Skills.
Duration of illness took precedence over ago at onset 
and was entered first at step l, but neither duration of 
illness nor age .it enact showed a significant contribution 
to variation in Linguistic Skills until tho influence of 
present age had been part ialled o u t . In the final regres­
sion analysis, the unigue r tributtons of duration of 
illness (F (1 , 37 ) -! 2 , t 9 ; p r(), 0 1) , age at onset (F( 1 , 37=15, 08; 
[><0,01), present age (m (1, 37) “ i 6, 4 5; p <0,0 U  and depression 
(F (i , 37 ) =7 ,1 5 ; p<0,f)r>) were all significant. Linguistic 
Skills was unaffected by sox.
The simple correlation coefficients computed between 
Linguistic Skills and dura t i' ' 1 Incss (r=-0,08-i7) ,
age at onset (r=-0,0115) go (r— 0,1133) and
depression (r=-0,3460) t m  at the patient who
T a b  t e  11
Multiple Regression of Lirujuistic Skills 
on Present A ge, Duration of Illness, 
Aye at Onset, Depression and Sex
Predictor Variable JT F« Change in R 2 Fb
Duration of 111m-ss 0 , 0 1 0,3C
Age at Onset 0,01 0,23 0,00 0, 18
Present Age 0 , 2 9 5,43* 0 , 2 8 1 Ji, 6 7 * *
Depression 0,41 6 , 6 0 * 0,12 7,41**
5 , 3 5 * 0,01
a - test ol tiiv null Itypochusis that R2 = 0 (df=k,N - k - 1) 
 ^ - tcsl of tho null tiypotlie;;is that change in R2=0 
(df= 1,N - k - 1)
« p < 0,05
verformud pot-.rly on f,tmmistic Skills was the more 
doprtissed, oJdcf patient who hnd boon ill for a longer 
period ttnw, with <!isi-.Tst- onset having occurred at a 
yourtf/cr n</c. This indic.itns that Linguistic Skills is 
a more omot ionally vu! nc-i able measuvt' o£ cognitive func­
tioning Ilian both Intnllect and Memory.
CHAPTER 8
DISCUSSION
The major flndinqs of i he proaont ist-udy indicate that 
cognitive functioning ,imon<i PD p.iiipnts is characterised 
by a continuous dis t rilm l ion, r<.mq inq from the intellec­
tually intact to the severely impui.-:d, with the level 
of functioning influenced hy >i complex of ti^-related 
variables. These variables are present ago, age at. 
onset and duration of illness.
Because of the hiuh infercorrelation he'ween these three 
variahios, it is difficuli. to separate their respective 
effects. To examine the influence of any one of these 
variables involves the indirect examination of the others. 
Kerlinycr (1073, p.AJZI p<'i nts- out: "Tuc mnco Independent 
variables arc i n l.ercorrel a ted , I he more difficult the 
interpretation (because) one has qrcater difficulty in 
tcllinq the rela i ivo influences of tin- independent vari­
ables on the dependent variable".
The multiple regression analyse, dcm msLraied the co- 
influence of I liose t Ime-rvl a !<>d arialiles on cognitive 
functionin']. To add to the i rtf • ,<rotat-ion difficulties 
created by the close re lat ionr.'-.p U-- tvjecn the throe vari­
ables, no regular pattern of i • i luenci emcrqed from the
analyses of their /'Heels on . ' . fnt aspects of coqnitive
functioning. For ins Lance, p: •. i age was shown to
absorb the sign! 1 leant, contri: • 't. of both aqo at onset
and duration of i l l m s s  to gen.M-.. ■ intellectual functioning, 
yc.t the unique contributions r>; both ago at onset and
Vduration of illness to linguistic skills functioning only 
became evident once present ago bad been controlled, The 
nature of the respective influences and relative importance 
of those three variables are difficult to determine and 
these complexities should be borne in mind as the results 
of the multiple regression analyses are discussed.
firstly, as a general description of the pa j.ant sample, 
our older patients had experienced disease onset at a 
later age and had been ill for a she ter period of time. 
Conversely, our younger patients had experienced disease 
onset at a younger age and had been ill for a longer 
period of time.
Of the cognitive component;; examined here, general in­
tellectual funct ioninsi (Intellect) embodied the "higher" 
or more intellectually demanding aspects of cognitive 
functioning. Although all three time-related variables 
produced significant contributions to variation in 
general Intellectual functioning, present age was the 
only variable whose unique contribution remained sig­
nificant once all other variables had boon statistically 
controlled. The strongest predict or of general intellec­
tual functioning was present ago: the older the patient, 
the poorer his intellectual performance proved to be.
These findings are compatible with those of a number of 
other researchers (Celcaia & Wnnam.ikor, 1972; Gurron et al.
J 972; Marttila 6 Rinne, l‘)7h). However, present ago 
must not bo regarded as simply reflecting chronological 
age. Several studies have shown PU patients to consistently 
perform worse than age-m.il cbod con I ro Is (Bowen ot al., 1975; 
Horn, 1974; l.oranger et: al., 1972; Reitan s Boll, 1971) . 
Present age in the PD context reflects disease-related 
phenomena and becomes a complex Interaction of the disease 
process and the natural aging process, which is also 
statistically indicated by the high intercorrelation 
between the throe time-related variables.
The descriptive trvnd mentioned previously would suggest 
that the older patient with poor general intellectual 
functioning is more likely to Live experienced disease 
onset at a later ago and been 111 for a relatively short 
period of time. This does no I mean that the length of 
time the illness has boon in progress has no influence 
on cognitive impairment in I’D, but rather indicates that 
the deleterious effects of the disease develop more 
rapidly when onset occurs at a later aye. Licberman et al.
(1979) found dementia to rarely occur in those patients 
who experienced onset before age 60, and other studies 
have shown dementia to bo particularly prevalent among 
late-onset patients (Gurrcm ot al., 1972; Marttila &
Rinnc 1976). In these studios duration of illness did 
not play a decisive role in cognitive dysfunction.
However, Celosiu and Wanamakor ( 1972) found demented 
patients to have been ill for longer than non-demented 
patients. The G.trron study used a smaller sample and 
quite different assessment techniques, but the research 
procedures of the other two studies were essentially 
similar with no methodological reason to account for 
the differences in findings. The significant contribution 
of duration of illness to general intellectual functioning 
shown in the present study indicates that the effects of 
this variable demand consideration oven though its role 
in cognitive dysfunction remain unclear.
In one particular aspeci of physiologicnl functioning, 
namelv cerebral metabolism, the work of Lavy et al. (1979) 
suggests that disease duration is not a strong determinant 
of disease effects. They measured regional cerebral blood 
flow (rCRF) in PD pai ionts and found it tv be significantly 
reduced, particularly in olderly patients with dementia.
The decreases in rCBl' in the elderly PD patients far 
exceeded the ’'physiological1' rCBF decline associated with 
advancing ago as soon in normal control subjects. These 
researchers expected the reduction in rCBF to correlate
with the length of time the patient had been ill as a 
reflection of a combination of advancing age and disease 
effects, hut- iCBF was reduced regardless of disease 
duration, kjther, it was significantly linked to age 
and the presence or absencc of dementia.
The importance of age ai disease omsut as a determinant of 
disease effects was further demonstrated in the results of 
the multiple rccjress-ion analysis performed on the Memory 
component. In addition to present age, age at onset 
emerged as a significant predictor of memory span function­
ing . The patient with poor memory span was older and had 
experienced disease onset at a Inter a g e . This implL. 3 
that, of the cognitive components examined here, memory 
span was the most affected by late onset which would 
suggest that those brain structures involved in memory 
span functionin. arc most vulnerable to the late develop­
ment of P D . The hippocampus may become more susceptible 
to senile plaque and neurofibrillary tangle formation 
(or the cholinergic system nay be more vulnerable to 
disruption) with advancing age, and therefore may be more 
easily damaged by late-onset PD.
The composite i.-ifl uence of the independent variables 
selected for investigation here, explained only 27% of 
variation in memory span, whereas they explained 41% of 
variation in general intellectual functioning and 42% 
of variation in linguistic skills. The remaining 73S 
of variation in memory span would be explained by error 
and variables not included in this study.
One would presume that impaired memory span would be a 
direct consequence of brain changes caused by ag.ing and 
the disease process. If so, the disease-related predictor 
variables ought to reflect these brain changes and there­
fore produce higher contributions to variation in memory 
span than shown here. However, memory span is also a
strong measure of attention and freedom from distract- 
ability. Variables such as test-taking anxiety, 
tiredness and premorbid cognitive abilitv way be some of 
the variables contributing to the unexplained variation.
The profile of the patient who performed poorly on 
linguistic skills is quite different to the poor performer 
on the other two cognitive components. He is the older, more 
depressed patient, who suffered disease onset at an early 
age and has been sick for a longer period of time. This 
is the only component where duration of illness emerged 
as a significant predictor. It is unlikely that those 
brain structures responsible for the perfon ce of 
linguistic skills are selectively more affected by the 
duration of PD than those involved in general intellectual 
functioning and memory span. As a component of cognitive 
functioning, linguistic skills is rather different to 
the other two components. Whereas both general intellec­
tual functioning and memory span develop spontaneously, 
the acquisition of linguistic skills demands organised 
training. As trained skills, proficiency would depend 
to some extent on the practise of these skills which may 
be affected by the emotional status of the patient.
It is possible that the latc-onset PD patient would have 
made some emotional adjustment to old age and have 
developed an acceptance of n general decline in health 
prior to PD onset, unlike the younger, early-onset PD 
sufferer who probably expected deteriorating functional 
ability to be a consideration for the future rather than 
of immediate impo'-t. The diagnosis of PD for the younger 
patient sets him apart from his relatively healthy peer 
group and the disease may disable him to the extent that 
his working life has to be cut short. The sufferer may 
become increasingly depressed at the progressive limita­
tions placed on his lifestyle by the disease and the 
failure of antiparkinson drugs to offer a cure. As a
consequence of this emotional state, he is likely to 
become less interested in events around him. He will 
read less and find less reason to write. As he generally 
makes less use of his linguistic skills, his proficiency 
will decline.
This positions depression as reactive rather than being 
an integral part ot" PD. The views of other researchers, 
as to whether depression is a primary or secondary 
consequence of the disease, remain at variance. Riklan et 
(2 973) suggested thft it was psychogenic, yet Marsh and 
Markham (1973) said that it was probably not psychogenic. 
Markham et al. (1974) said that it was not clear whether 
depression was a primary or secondary effect, while 
Robins (197 6) claimed that both primary and secondary 
elements were operative. It is difficult to evaluate 
depression in PD and the nature of this relationship 
set;ms open to the interpretation of the individual 
researcher.
The present study showed depression to be significantly 
related to one component of cognitive functioning, 
namely linguistic skills, but not to affect cognitive 
functioning as a whole. Mayeux et a l . (1981) also 
found depression to be significantly related to aspects 
of cognitive functioning: calculations, digit span 
and visuomotor tasks . Besides sample size (the patient 
sample used in the Mayeux study was larger than the 
present sample - 55 patients as opposed to 43), there 
is little difference in the demographic profiles of 
the two samples to account for these differences. The 
source of the discrepancies may lie in the different 
assessment techniques utilised: Mayeux and his colleagues
used the Beck Depression Inventory and a modified version 
of the Mini Mental State Examination.
Depression showed no significant relationship with present 
a ge, age at onset, duration of illness or s ex. These 
results substantiate the findings of Horn (1974), Markham 
et al. (1974) and Robins (1976).
Depression in PD demands further examination. Definitive 
conclusions may, however, only be established by research 
in the biochemical area. The role of the loss of central 
monoamines in causing, or contributing to, depression in 
PD patients remains to be fully investigated.
Dementia would most reliably be indicated by severe 
impairment in general intellectual functioning and memory 
span rather than linguistic skills, the latter having 
been shown to involve trained cognitive operations which 
are more easily influenced by emotional factors. The 
time-related variables would, therefore, be stronger 
predictors of dementia in PD than depression and sex 
which exert only negligible inf.1 Although at
present the exact nature of the ive influences
exerted by the time-related varia. on cognitive 
dysfunction remains unclear, there is no indication that 
any subgroup of patients exists which responds differently 
to their influences.
The cluster analytic investigations failed to demonstrate 
the existence of a group of sufferers susceptible to 
dementia, or a group of sufferers resistant to dementia.
The failure of major groups to emerge when the three 
cognitive components were explored separately and in 
combination suggests that subgroups do not exist in 
relation to aspects of cognitive functioning or overall 
cognitive functioning. The continuous distribution that 
was found to characterise cognitive functioning among PD 
patients indicates that demented patients, rather than 
constituting a subgroup of sufferers, represent the 
severely impaired extreme of the distribution.
It is a criticism of the present study, and in fact a 
drawback of research into cognitive functioning in PD 
in general, that although psychometric testing provides 
the most reliable method of mental status evaluation, 
the severely demented sufferers must be precluded from 
this form of assessment because of the nature and extent 
of their mental disability. We are therefore forced to 
draw conclusions based on the trends which emerge from 
the performance of less severely impaired sufferers.
A continuous distribution of cognitive functioning among 
PD patients is in accordance with bhe findings of 
Pirozzolo et al. (1982). These researchers concluded 
that a continuum of cognitive deficits appears in PD 
patients. Deficits occur in a graded fashion throughout 
.the patient population and are not restricted to any 
subgroup. Both the present study and the Pirozzolo 
study used psychometric measures, but the latter included 
a number of visual-spatial and timed motor response 
tests. The disadvantage of using visual-spatial and 
motor tests in assessing cognitive functioning in PD 
patients was discussed in Chapter 5. Their results are 
therefore contaminated and for this reason the present 
study cannot be regarded as providing unequivocal support 
for their findings.
It is difficult to compare the present findings with those 
studies which identified the existence of subgroups of 
sufferers because of differences in assessment techniques 
and research procedures. However, the careful examination 
of two of these studies in particular raises the possibility 
that their results may mask a continuous distribution of 
cognitive functioning among PD sufferer .
Lieberman et— al. (1979) found two subgroups of patients 
and concludcd^that two separate disease disorders could 
be distinguished: one, exclusively a motor disorder
Twith a longer and more benign course occurring in a 
younger population, and the other, a motor followed by a 
cognitive disorder with a more fulminant course occurring 
m  an older population. There are methodological limita­
tions to this study which warrant discussion.
Firstly, these researchers used a subjective clinical 
interview technique to assess the mental status of their 
patients. This form of assessment technique is not 
suitable for research purposes, as noted earlier. Secondly, 
they separated the severely and moderately demented from 
the remainder of the sample and thereby experimentally 
manipulated the patient sample to create two groups. 
Lieberman {l974), when conducting an earlier study, wrote:
"I have chosen to include only those patients with a 
moderate dementia (in one group) because as a group they 
can be clearly differentiated from normals without resort 
to detailed psychometric testing" (p.72). In the 1979 
study, the same procedure was employed for presumably 
the same reason. Their research procedure may have 
produced two groups with significant group differences 
but in reality they may have disguised the existence of 
a single, homogeneous group of sufferers. Cognitive 
functioning assessed with sensitive psychometric techniques 
may have demonstrated a continuum with no true breakpoint.
Boiler et al. (1980) correlated pathological data obtained 
at autopsy with clinical data of cognitive functioning 
obtained from hospital files. The fallibility of assessing 
intellectual status at time of death from historical data, 
gathered from interviews with clinical staff, is clear. The 
patient sample was divided into throe groups: the severely 
demented, the mildly demented and those of normal status. 
Boiler and his co-workers found a significant incidence of 
pathological pointers characteristic .f AD (namely, senile 
plaques and neurofibrillary tangles) in the bra ins of 
those patients assessed as being demented. The demented
group differed from the non-dementcd group in having a 
significantly higher moan senile plaque density. (It 
should be noted that the non-dementcd group was not 
totally free of senile plaque formation, as will be 
discussed later.}
These findings load these researchers to propose that 
two forms of PD may ;xist: the first with neuropathological 
changes limited to the basal ganglia and no dementia, and 
a second form with subcortical PD changes and cortical A.D 
changes with dementia. However, the evidence of two 
groups of sufferers is not distinct. Firstly, a range 
of cognitive functioning among the patient sample was 
evident, and it. must be acknowledged that the points of 
division between the severely demented, the mildly 
demented and normal status categories would, of necessity, 
have been arbitrary. Secondly, some patients who were 
classified as being of normal status showed AD changes 
while some patients with mild dementia had none of these 
changes. So, although a significant number of severely 
demented patients showed AD changes, and a significant 
number of patients with normal status showed no AD 
changes, there is a blurring of barriers.
Other studies have identified subgroups of sufferers by 
examining cognitive functioning in relation to motor 
deficits. Mortimer et al. (1992) correlated cognitive 
functioning deficits with measures of bradykinesia, 
tremor and rigidj ty. They found a significant relationship 
between severity of bradykinesia and decline in .intellec­
tual performance. The same relationship was not shown 
between severity of other motor symptoms and intellectual 
performance. Rather, tremor showed a significant inverse 
relationship with scoros on a test of spatial orientation 
memory. These researchers then proposed that there are 
two forms of PD; one with predominant tremor and relatively 
intact intellectual functioning, and another wit-h marked 
bradykinesia and cognitive impairment.
The inferential leap from results to conclusion is un­
founded for a number of reasons. The correlation between 
motor symptoms failed to reach significance. Their study 
did not prove that PD patients chow predominant brady- 
kinesia or tremor to the extent that patient subgroups 
could be distinguished on the basis of predominant 
motor symptoms. Also, bradykinesia showed significant 
correlations only with measures of visual-spatial 
behaviour and psychomotor tasks, and failed to show 
significant correlations with measures of "higher" 
intellectual functions such as "fund of information" and 
"verbal memory". These results therefore show a sig­
nificant relationship bolweon the impairment of motor 
and visual-spatial behaviour, which is predictable as 
both behaviours arc controlled by the same subcortical 
structures damaged by PD (Boiler, 19821. Sparse evidence 
is provided for the existence of two forms of PD. Also, 
Marttila and Rinne (1976) found tremor to be more severe, 
rather tiian lesr- cvr , in patients with dementia.
No major methodological criticisms can be levelled at 
Garron et al. (1972). They found that they could divide 
PD patients into a "fast" and a "slow" group on the basis 
of combined motoric and intellectual response time. The 
distribution of response time scores "tended" to be 
bimodal. The two groups which emerged from this bimodality 
showed significant group differences wilh respect to aye 
at testing and age at onset. The "slow" group was older 
and had experienced late onset of the disease. The 
researchers failed to report on the distribution of the 
number of items correctly answered. If bimodality had 
Loen demonstrated, patient subgroup:; based on cognitive 
functioning differences would have been suggested.
Garron and his co-workers investigated aspects other 
than the status of cognitive functioning. By examining 
the speed of intellectual functioning, a qualitative
dimensi. f cognitive functioning was measured. Also, 
a motoric • j - t  was introduced in combination with the 
cognitive .■ mtk nt as patients wore required to manually 
oi crate the sci! • testing apparatus. Their study raises 
the interesting possibility that subgroups of patients 
may exist with respect to 1 lie interaction of PD disease 
symptomotology.
The question oi patient, subgroups may be approached from 
two premises. Firstly, subgroups of patients could 
indicate patient subtypes which, by virtue of individual 
attributes resulting from consf i tutional, environmental 
or psychological factors, rornond differently to the 
samt disease proven . Secondly, subgroups could provide 
evi-.-’nee for disease im,,types wi -h produce varied disease 
symptomotology.
The present fxndings have implications for both premises.
-Vc subgroup of sufferers appears to exist that is 
particularly susceptible to, or resistant to, dementia.
The continuous distribution of cognitive functioning 
nut emerged suggests u wide variability oi patient 
responses to the dementing process associated witn PD. The 
“ ffects of this process appear to be dependent on individual 
attributes which are not identifiable as the collective 
features of patient subgroups. An homogeneous patient 
group suggests the effects of a single disease process.
The range of differential functioning probably reflects 
xarying stages of degeneration. For example, when disease 
damage is confined to subcortical regions, little or no 
cognitive impairment is produced, but. with progressive 
involvement of cortical regions more extensive and severe 
impairment becomes evident. This would support the views 
of Boiler ct a l . (1980), Botez and Barbeau (19731, Hakim 
and Mathioson (1979) , Licberman (1974), Mayeux et al. (1983) 
and Sweet ct al. (1976).
It may be challenged that the continuum of cognitive 
Impairment may be consequent upon subcortical damage 
alone and that we are examining a subcortical dementing 
condition. It cannot be refuted that the influence of 
subcortical damage is reflected in tho cognitive impair­
ment in PD sufferers. However, there is no evidence to 
substantiate only subcortical involvement at a functional 
level. Boiler et a l . (1980) write;
In PD...lesions of deep subcortical nuclear 
struct ures may be responsible for the changes 
in mental status sometimes referred to as 
subcortical dementia. However, our patients 
with mild dementia do not fit the clinical 
description of subcortical dementia, and they 
had neither the marked personality changes 
nor (specifically) the defective ability to 
manipulate acquired knowledge characteristic 
of that condition, (p.333)
Also, Mayeux et al. (1983) found no significant differences 
between the neuropsychological functioning of AD patients 
(supposedly cortically demented) and PD patients (supposedly 
subcortically demented). The failure of motor symptom 
severity to significantly correlate with the severity of 
impairment in aspects of cognitive functioning historically 
accepted to be cortically controlled suggests subcortical 
ana cortical involvement in PD (Mortimer et al., 1982).
The cognitive changes seen in subcortical dementias are 
described as resembling those seen in the cortical 
dementias wl'u tho prominent exception of preserved lang­
uage function. "Almost all aspects of language function 
are undisturbed including reading, writing, speaking and 
comprehension" (Heilman a Valonstcin, 1979, p. 486). If 
we evaluate the performance of our patient sample on the 
measures of reading, writing and comprehension used here, 
it is clear that these aspects of language are not un­
disturbed. A range of language functioning from
intact to impaired is evident which would suggest that 
impairment reflects more extensive neurological damage 
than the subcortex alone.
When subcortical and cortical dementias are discussed, 
the criteria for dementia must be clarified. As Mayeux 
et al. (1983, p.282) point out: "If dementia refers to 
an acquired intellectual impairment, then..-PD should 
be so characterised. However, if more stringent criteria 
are applied, such as the presence of aphasia and agnosia, 
then (PD) might be exempt in (its) early stages". As 
aphasia and agnosia are symptoms of cortical dementia, 
Mayeux1s words intimate a progression of the Parkinson 
dementia to cortical structures.
On a structural level, the neuropathological evidence 
gathered by Hakim and Mathioson (1979) and Boiler et al. 
(1980) indicates subcortical and cortical involvement. 
Strong support for these findings is offered by the 
work of Whitebouse et al. (1983) and their discovery of 
the loss of cholinergic neurons in the basal forebrains 
of demented patients with PD which provides a morphological 
link between subcortical and cortical degeneration in PD. 
Whitehouse and his colleagues s ay:
Since demented patients with PD have plaques 
and neurofibrillary tangles and show loss of 
neurons in the nucleus basalis of Meynert, we 
believe that, similar pathophysiological mech­
anisms may operate in the dementias of AD and 
PD. Clinically, the cognitive symptoms in AD 
and PD have been referred to as examples cf 
cortical and subcortical dementias, respectively.
The overlap in clinical, pathological and neuro­
chemical features between AD and PD, coupled 
with the demonstration of neuron loss in the 
nucleus basalis of Mcynort in both diseases, 
may require reworking of this concept. (p.246)
Theoretically, the PD process may observe a neurological 
"pathway" of degcneration. The PD degenerative process
has a particular affinity for the dopaminergic neurons 
of the subsuanti-; nigra (Rinne, i978) and this is where 
the process begins. Then it spreads, with Lewy bcdy 
formation and neuronal loss in the caudate nucleus, 
globus pallidus and ['utamen (Pearce, 1978) as well as 
the hypothalamus (Mayoux et a l ., 1981). A striatal 
dopamine depletion occurs and on increase m  acetyl­
choline activity takes place (Pearce, 2978). The 
characteristic motor symptoms are manifested together 
with visujl-sontio1 perception and behaviour deficits 
(Boiler, 1962). It is possible that at this point 
there may be other subtle changes in aspects of cognitive 
functioning in which these subcortlcal brain structures 
are involved, either on an individual basis or in a 
systemic arrangement -ith cortical structures. Toe 
degeneration then spreads further, resulting in a loss 
of cholinergic neurons .in the basal forebrain and 
parti-ularly in the nucleus basalis of Meynert which 
forms the pathological substrate for the loss of pre- 
synaptic cholinergic markers in the cortex (Whitehouse 
et al., 1983). Cortical acetylcholine activity ir 
reduced, cortical senile plaques and neurofibrillary 
tangles form, and progressive cognitive dysfunction 
occurs.
It would be an oversimplification of a highly complex 
disease procesn tn propose that this pattern of degener­
ation occurs in all PD patients and that dementia is the 
inevitable outcome. Any experienced clinician will 
confirm the observation that while some PD patients 
become demented, others remain remarkably intact. With 
reference to thr present findings, the intellectually 
intact and demented patients would oe representatives of 
the extreme ends of our continuous distribution rather 
than being nemlK-rs of separate qroups.
The objective of PD research is to establish the boundaries 
of the primary disease process. Once the brain structures 
and biochemical systems disrupted by disease damage are 
known, the behavioural manifestations of the disease can 
be evaluated in relation to disease pathology, the ultimate 
goal being the development of new and more effective thera­
peutic approaches. Unfortunately, as is well-known, 
human behaviour often defies reductionism and this is 
no less evident in PD.
The work of Hakim and Mathicson (1979) and Boiler et al.
(1980) has been mentioned before but will be discussed 
further. Not only does the work of these researchers 
illustrate the complexities of PD and the issue of behav­
iour in relation to brain changes, but it also provides 
some neuropathological support for the present findings 
of a continuous distribution of cognitive functioning in 
PD patten's.
Hakim and Mathieson (1979) examined the brains of 34 
patients meeting neuropathological criteria for PD (Lewy 
bodies in the substantia nigra or locus ceruleus). They 
found evidence of histological changes characteristic of 
AD in 33 of the 3^ patients. Specifically, these changes 
were senile plaques in the hippocampus (85% of patients), 
neurofibrillary tangles in the pyramidal cells of the 
hippocampus (85% of patients! and granulovacuolar changes 
in the hippocampal neurons (88§ of patients). Age- and 
sex-matched controls showed a significantly lower incidence 
of these changes than the PD patients.
A number of histopatbologi.cal and behaviour anomalies were 
found when comparing the autopsy findings with clinical 
notes concerning the cognitive functioning of the patients 
prior to death. The one patient free of all AD signs was 
a 70-year old man who had been ill with PD for many years 
and who had displayed symptoms of dementia for many years.
(Exact figures were not on file.) Fourteen patients had 
no descriptions on file of demented behaviour yet all of 
these patients showed evidence of AD brain changes. Many 
of the patients noted as having florid dementia showed 
markedly less severe AD histological features than a 
large proportion of those patients who showed no dementia. 
Unfortunately, the clinical criteria for dementia were 
not given.
Boiler et al.’s 2980 proposal of the existence of two 
forms of PD distinguishable by differences in pathology 
and symptomotolgy was not supported by their findings.
On autopsy, they examined 36 cases with a pathologically 
confirmed diagnosis of idiopathic PD. {Criteria for PD 
were neuron loss and Lewy bodies in the substantia nigra.)
A search for senile plaques and neurofibrillary tangles 
was made in sections of the cerebral cortex and hippo­
campus .
Twenty patients (56*6 of the sample) showed some evidence 
of AD changes: senile plaques and/or neurofibrillary 
tangles. Fifteen of these patients (42% of the sample!
."net the criteria for a pathological diagnosis of A D . Of 
these 15 patients, 3 had been clinically assessed as being 
of normal mental status until death. Of the 16 patients 
showing no AD lesions, 4 were clinically described as 
being mildly demented. (The assessment of intellectual 
status was based on interviews noting alertness, affect, 
orientation, language functions, immediate, recent and 
long-term memory, insight and abstract reasoning.)
These studies demonstrate the high incidence of AD changes 
in PD patients which would explain the high incidence of 
dementia in PD patients. They show that these cortical 
changes vary in quantity and quality and could produce a 
gradation of cognitive functioning among the PD population. 
These studies also indicate the complexities of correlating
morphological changes with manifest behaviour because 
some patients assessed as being demented (albeit mildly) 
showed no cortical involvement while other patients 
assessed as normal wouid have been diagnosed, on patho­
logical grounds, as being AD sufferers.
Dementia in PD is strongly age-related a= it has been 
shown to be prevalent among those older patients who 
suffered late disease onset (Garron et al ., 1972;
Lieberman et al., 1979; Marttila & Rinne, 1976). This 
age-related trend is supported by the present findings 
although the evidence is not conclusive.
h number of brain changes that occur as the natural result 
of the aging process are similar to those occurring as 
the pathological result of PD. With respect to subcortical 
aging, a marked decrease in striatal dopamine has been 
shown to occur with advancing age in normal humans (Lavy 
et al., 1979), and it is the major biochemical correlate 
of PD. Mann and Yates (1982) point out that in old age 
there is an obvious loss of pigmented nerve cells from 
the substantia nigra and atrophy of those that remain, 
which is a major structural change occurring as a result 
of PD. With respect to cortical changes occurring with 
natural aging, regional cerebral blood flow levels are 
reduced and cholinergic levels may be reduced, not to 
pathological levels but to the extent of predisposing 
the aging brain to pathological changes should aggravating 
factors (like PD) intrude (Mann & Yates, 1982).
Early-onset PD has been associated with a slow evolution 
of the disease (Pollock & Hornabrook, 1966) and this may 
be due to the disease attacking a younger, healthier brain. 
Late-onset PD produces an acceleration of the disease 
process so that within a relatively short period of time 
the patient becomes severely disabled in all aspects of 
the disease (Pederzoli et al., 1983). Early-onset PD may
be d' . •'ribed as "premature aging" of the central nervous 
system (Mann & Yates, 2982) with aging changes occurring 
earlier chan in normals. Late-onset PD may be described 
as "accelerated aging" as it produces an increase in age- 
related changes already in progress. When onset occurs 
later in life, the aging brain is particularly vulnerable 
to disease attack and pathological changes are facilitated 
in both the subcortex and the cortex placing the elderly 
patient at a much higher risk of dementia.
Dementia in PD is a reflection of the extensive neurological 
damage brought about by the progressive degenerative disease 
process. The present study has identified the age of the 
patient, the age at which disease onset occurs and the 
length of time the disease is in progress as important 
determinants of cognitive dysfunction. In my opinion, 
it is the task of future research to separate their effects. 
A series of studies involving the experimental control of 
these variables will be required to establish the relative 
importance and nature of influence of each individual
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APPENDIX I
ABBREVIATED FORMS OF LURIA'S NEUROPSYCHOLOGICAL INVESTIGATION
MEMORY SUBSCALE
1. I dm goiny to say svv«?n words. After I finish saying them, I 
want you to n’puat an numy of them back to me as you car. 
romombir. rPrvsvnt words at the rate of one per second.)
house forest cat night table needle pie
(Have subject rc-ul 1 ,vs many of the words as posr.ible. Go on 
to trial if #UUjcv: ih unahiu to recall another word, or
if subject hu:i recalled .ill seven words.)
Ycj rer.enl;pre j _  worilts out uf tno seven o.i thd t trial. I am 
going to say the same sev.M wor Is ag xi.i and I want you to try 
to recall as nvany as you cun. Pluas^ bocjii. only after I have 
finisned. However, before I begin, I want you to tell me how 
many v,ords you tldnk you will rcnember this next time after I
finish sayin.j thp word:; again. Remember, you got   out of
seven on the ia; t trial. (Do this for each trial until subject 
reaches two perfect trials in a row or five trials.)
2. I wa.it you to remember some words that I am going to say:
Repeat them. Now look at this picture. What do you see? 
(Present Card A and have subject describe picture for 15 
seconds.) Now can you toll me, what were the words I asked 
you to remember:
house (__) tree ! ) cat (__)
3. I want you to remember some other words : 
table carpet flower 
Repeat them. Now look at this picture. What do you see? 
(Present Card B and have subject describe picture for 15 
seconds.) Now can you tel 1 me, what were the words I asked 
you to remember.
table (_) carpet I ) flower (__)
4. Now X .in going to say some words and I want you to try and 
remember then:
5. Now I am going to read two sentences to you and I want you 
to remember them.
“The sun rises in the uast." Piuaso ’tipcat that.
"In May the apple trees (ilosiriora.' Ploaao repeat that.
Wliat was the first, ro h^ hc o.'
(The sun riaoa in tin' vast .   )
What was the second ;u>nt.imicvV
(In May the op.pl o troosj hlo;:;iora. )
you say.’ iProraptr subject
liomc pictures. With each picture,
I finish, I will show you thr> 
nay the word that goes with it.
'■i tinpicture (present Card A) 
ow you th<- picture later, '.hat would 
I' necessary.) You will have five
Car 1 0 (eaplv.ymvi
Carl F. (party)
Card P (happy)
(family) 
(project) 
(pollution)
call you* brol her' v, iathvr".'
RECEPTIVE SPEECH SUBSCALE
1. (Place a pencil, a key and a comb clockwise in a triangle 
before the subject.)
Point at the pencil. __
Point at the key.______ __
(Keep the triangle of pencil, key and comb on the table.)
Point with the key to the pencil. ___
Point with the pencil to the key._____
3. (Keep the triangle of pencil, key and comb on the table.)
Point to Clio pencil viUi the key. ___
Point to the comb with the pencil.
*1. Will you tell me whether the "father's brother" and the 
"brother's father" are two people or the same person)'
5. What would you call your "father's brother"? (Uncle __)
What would you call your brother's father".' (Father ___)
(Give subject response paper.)
6. I would like you to draw a cross beneath a circle. (__ )
7. ,T would like you to draw a circle to the right of a cross.
I >
8. Tell me which is right:
"Spring comes before summer" OR "Summer comes before spring"? 
(Spring comes before summer. __ )
9. Which boy is shorter if Tom is *ul lur thorn Amie?
iO. Please listen to thin statement:
"The woman who worked at the store come to the school where 
Mary studied to give a talk."
Who gave the talk.' (The woman.   )
What was Mar/ doitta.' (Studying, attending school. ___ 1
EXPRESSIVE SPEECH SUBSCALE
v you somi- card'; with sentences that have a 
MMO <jiv<; me a word that you think can fill
t . Make up a sentence 
(Present Card N.)
i. h'ow I am 'jouuj to aive you .1 car I on which the words arc mixed 
up. If flu-y ire arr mqi’il • m - v t  ly they can make a suntencc.
I w.uif you 1 u .in\ui-ii' tln-m ;o that they do make a sentence.
(If oilJp'Ct je.ipnn.lc incorrectly, nay: "Ttiat is not quite
riqht. Keep t lymn.")
i’rc.ient Card »'>. (I spike to the doctor shout my headache. ___ )
Present Card P. I I feel much better today than I did yesterday.

WRITING SUBSCALE
(Hand subjoct rasponsq paper.)
1. I would like you to write your name for mo.
2. I am going to dictate a sentence to you, and I want you to 
write it down on your uhc-et of paper.
"All of a sudden it began to rain."
3. Now would you plvnno write:
"Jack and Jill went up the hill."
■i . (Hand subject mock-up of . )
tow would you please complele this for me an you would a real 
choose. Make the che-pie out to the value of one hundred rand. 
You can make it payable to whomever you wish, but I want you 
to rujh your own name at lie- !>ot Lorn.
New would you please write a sentence for me. Make up one of
VWRITING SUBSCALE
(Hand subject romponmc pupi'i ,)
1 . I would like you to writv ysur name’ for mo.
2. I am going to lUvt.-m- d ;ii?iit.'nci to you, and 7 want you to
writ-; it down on youv shout of p.ipor.
"Ml of a audJem it Liugan to r.iin."
3. Now would you plixiiiv write:
"Jack and Jill wont up thi> hill."
4. (HuriJ gob]vet mou-k-.ip of ct.oquc .)
Now would you pli/Auc oonploLt- thin tor nv as you would a real 
Lli'-.'quc. Mdko tho out t.o v.ho value of ont’ hundred rand.
You fcin mokr- it fdy^bU* to whom w o  r you wish, but I want you
to piqn your c-iwn luiiai* .it t!v- bo I turn.
5. How woul'i you plo.iik' wi i t r a non I once for mo. Make up one of
Writing Subscale
Amount
Bedraq
of Toonder
Writing Subscale
Amount
or nearer 
of Toonder
The cards used here correspond to the foil.iwimj cards from
Luria’s neuropsychological Investigations
doctor - ray - spoke - tht 
today - feel - much - die
• about - headache -
APPENDIX II
PEARSOP PRODUCT-MOMEWI CORRF.IAT1UN MATRIX
liifo Digits Similar
p=0,000
0,0000
M7 p-'O ,.!93
,0762 0,067 5
- 0 ,5 5 9 8  -0,5500
p-0,000 p=0,000
-0,4252 -0,4836
p*0,002 p=0,001
-0,4604 -0,5415 
p=0,003 p=0,000
-0,2493 -0,4410 
p=u,053 p-0,002
-0,4740 -0,4765
p=0,001 p-0,001
-0,1618 -0,1617 
p=0,ISO p=0,150
SAPSOM PRODUCT-MOMENT CC
Memory
SS£Sp
-0,62 30 0,4483 ,4b4"
p=0,000 p=0,001 p=.
O.-IGSU 0, ! JO".

i4
Author Basnett Den ice
Name of thesis Dementia In Long-term Parkinson's Disease Patients Receiving Chronic Levodopa Therapy. 1985 
PUBLISHER:
University of the Witwatersrand, Johannesburg 
©2013
LEGAL NOTICES:
Copyright Notice: All materials on the Un i ve r s i t y  of  t he W i t w a t e r s r an d ,  Johannesbu r g  L i b r a r y  website 
are protected by South African copyright law and may not be distributed, transmitted, displayed, or otherwise 
published in any format, without the prior written permission of the copyright owner.
Disclaimer and Terms of Use: Provided that you maintain all copyright and other notices contained therein, you 
may download material (one machine readable copy and one print copy per page) for your personal and/or 
educational non-commercial use only.
The University o f the W itwatersrand, Johannesburg, is not responsible for any errors or omissions and excludes any 
and all liability for any errors in or omissions from the information on the Library website.
